EG&G INC
8-K/A, 1999-03-10
ENGINEERING SERVICES
Previous: ECC INTERNATIONAL CORP, SC 13G/A, 1999-03-10
Next: ELCOR CORP, 4, 1999-03-10



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549




                                   FORM 8-K/A

                               AMENDMENT NO. 2 TO

                                 CURRENT REPORT




                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


       Date of Report (Date of Earliest Event Reported) December 16, 1998
                                                        -----------------




                                   EG&G, Inc.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)






      Massachusetts                 1-5075                  04-2052042 
     ---------------       ------------------------     -------------------
     (State or other       (Commission File Number)       (IRS Employer
     jurisdiction of                                    Identification No.)
      incorporation)                                   
                                                    


                45 William Street, Wellesley, Massachusetts 02481
               ---------------------------------------------------
               (Address of principal executive offices) (Zip Code)






                                 (781) 237-5100
              ----------------------------------------------------
              (Registrant's telephone number, including area code)




                                 Not applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)




<PAGE>   2
This Amendment No. 2 on Form 8-K/A amends and restates Item 7 of the Current
Report on Form 8-K filed with the Securities and Exchange Commission on December
30, 1998 by EG&G, Inc.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS


(a)      Financial Statements of Businesses Acquired

         The financial statements required to be filed were previously reported
         in the Lumen Technologies, Inc. (formerly BEC Group, Inc.) Annual
         Report on Form 10-K for the fiscal year ended December 31, 1997 and in
         the ILC Technology, Inc. Annual Report on Form 10-K for the fiscal year
         ended September 27, 1997 and are included in the Exhibits to this Form
         8-K/A.

(b)      Unaudited Pro Forma Financial Information

         On December 16, 1998, Lighthouse Weston Corp. ("Lighthouse"), a wholly
         owned subsidiary of the Company, completed its tender offer for shares
         of common stock of Lumen Technologies, Inc. ("Lumen"), which is engaged
         in the business of developing, manufacturing and marketing specialty
         light sources and related products for markets requiring advanced
         optical technologies. Lighthouse acquired approximately 92.3% of
         Lumen's common stock pursuant to the tender offer. On January 4, 1999,
         Lumen became a wholly owned subsidiary of the Company, as a result of
         the merger of Lighthouse with and into Lumen. The acquisition of Lumen
         by the Company was accounted for as a purchase. 

         The following unaudited pro forma consolidated financial information
         gives effect to the acquisition of Lumen and should be read in
         conjunction with the historical financial statements and related notes
         thereto for both the Company and Lumen (including the historical
         financial statements and related notes thereto for ILC). The unaudited
         pro forma consolidated income statements for the fiscal year ended
         December 28, 1997 and the nine-month period ended September 27, 1998
         give effect to the acquisition as if the acquisition was completed as
         of January 1, 1997, and combines the Company's and Lumen's historical
         income statements for each respective period. The unaudited pro forma
         consolidated results for the fiscal year ended December 28, 1997 and
         the nine-month period ended September 27, 1998 exclude
         acquisition-related charges of $2.3 million for purchased in-process
         technology related to Lumen.

         The unaudited pro forma consolidated income statement for the fiscal
         year ended December 28, 1997 includes columns representing the
         Company's historical results as adjusted for the 1998 divestitures of
         its Rotron and Sealol Industrial Seals businesses (previously reported
         on Form 8-K dated April 16, 1998) for the fiscal twelve months then
         ended, Lumen's historical results for the year ended December 31, 1997
         and ILC Technology, Inc.'s (ILC) historical results for the fiscal
         twelve months ended September 27, 1997 (which represented ILC's
         previous fiscal year end). ILC was acquired by Lumen on March 12, 1998.
         The unaudited pro forma consolidated income statement for the nine
         months ended September 27, 1998 includes columns representing the
         Company's historical results as adjusted for the divestiture of its
         Rotron and Sealol Industrial Seals businesses for the nine-month period
         then ended, Lumen's historical results for the nine months ended
         September 30, 1998 and ILC's historical results for the period from
         January 1 through March 12, 1998.

         The unaudited pro forma consolidated financial information is provided
         for informational purposes only and is not necessarily indicative of
         the Company's financial position or operating results that would have
         occurred had the acquisition been consummated on the dates, or at the
         beginning of the period, for which the consummation of the acquisition
         is being given effect, nor is it necessarily indicative of the
         Company's future operating results or financial position. The unaudited
         pro forma adjustments do not reflect any operating efficiencies and
         cost savings that the Company believes are achievable.
<PAGE>   3
         The unaudited pro forma consolidated financial information has been
         prepared using the purchase method of accounting, whereby the total
         cost of the acquisition has been allocated to the tangible and
         intangible assets acquired and liabilities assumed based on their
         respective fair values at the effective date of the acquisition. Such
         allocations will be based on studies and independent valuations, which
         are currently being finalized. Accordingly, the allocations reflected
         in the unaudited pro forma consolidated financial information are
         preliminary and subject to revision. It is not expected that the final
         allocation of purchase price will produce materially different results
         from those presented herein.




<PAGE>   4
                                   EG&G, INC.
                 UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
                               SEPTEMBER 27, 1998
                                 (In thousands)
<TABLE>
<CAPTION>
                                         EG&G           LUMEN
                                      HISTORICAL     HISTORICAL     PRO FORMA
                                        9/27/98        9/30/98     ADJUSTMENTS        PRO FORMA
                                     -----------    -----------    -----------       -----------
<S>                                  <C>            <C>            <C>               <C>
Current Assets:
Cash and cash equivalents            $   178,649    $     1,994    $      --         $   180,643
Accounts receivable                      210,449         26,701           --             237,150
Inventories                              107,446         29,878          3,204(B)        140,528
Other current assets                      67,825          1,730           --              69,555
                                     -----------    -----------    -----------       -----------

        Total current assets             564,369         60,303          3,204           627,876


Property, plant and equipment, net       165,828         38,813         15,156(H)        219,797
Investments                               14,717           --             --              14,717
Intangible assets                        114,974         45,249        141,997(C)        302,220
Other assets                              64,529          7,436           --              71,965
                                     -----------    -----------    -----------       -----------

           Total assets              $   924,417    $   151,801    $   160,357       $ 1,236,575
                                     ===========    ===========    ===========       ===========


Current Liabilities:
Short-term debt and current
 portion of long-term                $    22,962    $    25,411    $   162,050(I)    $   210,423
Accounts payable                          73,233         11,028           --              84,261
Accrued restructuring costs               38,571           --            5,000(F)         43,571
Accrued expenses                         195,730         24,044         20,984(E)        240,758
                                     -----------    -----------    -----------       -----------

        Total current liabilities        330,496         60,483        188,034           579,013


Long-term debt                           114,867         36,986           --             151,853
Convertible subordinated notes              --           14,648(L)        --              14,648
Other long-term liabilities              101,677          7,570           --             109,247

Minority interests                          --              237           --                 237

Common stock                              60,102            207           (207)(D)        60,102
Retained earnings                        605,286         34,215        (30,015)(D)       609,486
Accumulated other comprehensive
 income                                    1,178            (38)            38(D)          1,178
Cost of shares held in treasury         (289,189)        (2,507)         2,507(D)       (289,189)
                                     -----------    -----------    -----------       -----------

        Total stockholders' equity       377,377         31,877        (27,677)          381,577
                                     -----------    -----------    -----------       -----------
           Total liabilities and
            stockholders' equity     $   924,417    $   151,801    $   160,357       $ 1,236,575
                                     ===========    ===========    ===========       ===========
</TABLE>

The accompanying unaudited notes are an integral part of this pro forma
consolidated financial information.
<PAGE>   5
                                   EG&G, INC.
                UNAUDITED PRO FORMA CONSOLIDATED INCOME STATEMENT
                  FOR THE NINE MONTHS ENDED SEPTEMBER 27, 1998
                                 (In thousands)


<TABLE>
<CAPTION>
                                                    ROTRON &
                                       EG&G          SEALOL         EG&G          LUMEN         ILC TECH.
                                    HISTORICAL     PRO FORMA     EXCLUDING      HISTORICAL      HISTORICAL
                                     9 MONTHS     ADJUSTMENTS   DIVESTITURES     9 MONTHS     1/1/98 THROUGH
                                  ENDED 9/27/98       (A)         9/27/98     ENDED 9/30/98      3/12/98
                                  -------------  ------------   ------------  -------------   --------------
<S>                               <C>            <C>            <C>           <C>             <C>
Sales                              $ 1,055,705   $   (22,666)   $ 1,033,039    $   105,885    $     8,052
Cost of Sales                          793,809       (14,064)   $   779,745         69,156          5,661
                                   -----------   -----------    -----------    -----------    -----------
  Gross Margin                         261,896        (8,602)       253,294         36,729          2,391

Research and development
 expenses                               32,383          (302)        32,081          3,341            565
Selling, general and
 administrative expenses               172,519        (6,173)       166,346         20,275            989
Restructuring charges                   54,500          --           54,500           --             --
Merger, spinoff & nonrecurring
 charges                                  --            --             --           16,704           --
Asset impairment charge                  7,400          --            7,400           --             --
Gains on dispositions                 (125,822)      125,822           --             --             --
                                   -----------   -----------    -----------    -----------    -----------

Operating income (loss) from
 continuing operations                 120,916      (127,949)        (7,033)        (3,591)           837
Other income (expense)                   1,845          --            1,845         (4,131)           (55)
                                   -----------   -----------    -----------    -----------    -----------

Income (loss) from continuing
 operations before income taxes        122,761      (127,949)        (5,188)        (7,722)           782
Provision (benefit) for income
 taxes                                  41,227       (38,355)         2,872          1,702            238
                                   -----------   -----------    -----------    -----------    -----------

Income (loss) from continuing
 operations                        $    81,534   $   (89,594)   $    (8,060)   $    (9,424)   $       544
                                   ===========   ===========    ===========    ===========    ===========

Basic earnings per share from
 continuing operations             $      1.79   $     (1.97)   $     (0.18)
Diluted earnings per share from
 continuing operations             $      1.77   $     (1.94)   $     (0.17)

Weighted average shares of
 common stock outstanding:
  Basic                                 45,552        45,552         45,552
  Diluted                               46,089        46,089         46,089
</TABLE>


<TABLE>
<CAPTION>
                                      PRO FORMA
                                     ADJUSTMENTS          PRO FORMA
                                    ------------         -----------
<S>                                 <C>                  <C>
Sales                               $      --            $ 1,146,976
Cost of Sales                               487(H)           855,049
                                    -----------          -----------
  Gross Margin                             (487)             291,927

Research and development
 expenses                                  --                 35,987
Selling, general and
 administrative expenses                  4,825(G)(H)        192,435
Restructuring charges                   (54,500)(K)             --
Merger, spinoff & nonrecurring
 charges                                (16,704)(K)             --
Asset impairment charge                  (7,400)(K)             --
Gains on dispositions                      --                   --
                                    -----------          -----------

Operating income (loss) from
 continuing operations                   73,292               63,505
Other income (expense)                   (6,685)(I)           (9,026)
                                    -----------          -----------

Income (loss) from continuing
 operations before income taxes          66,607               54,479
Provision (benefit) for income
 taxes                                   16,242(J)            21,054
                                    -----------          -----------

Income (loss) from continuing
 operations                         $    50,365          $    33,425
                                    ===========          ===========

Basic earnings per share from
 continuing operations                                         $0.73
Diluted earnings per share from
 continuing operations                                         $0.73

Weighted average shares of
 common stock outstanding:
  Basic                                                       45,552
  Diluted                                                     46,089
</TABLE>


The accompanying unaudited notes are an integral part of this pro forma
consolidated financial information.
<PAGE>   6
                                   EG&G, INC.
                UNAUDITED PRO FORMA CONSOLIDATED INCOME STATEMENT
                      FOR THE YEAR ENDED DECEMBER 28, 1997
                                 (In thousands)


<TABLE>
<CAPTION>
                                                     ROTRON &
                                        EG&G          SEALOL          EG&G         BEC GROUP    ILC TECH.
                                     HISTORICAL     PRO FORMA      EXCLUDING      HISTORICAL    HISTORICAL
                                       FISCAL      ADJUSTMENTS    DIVESTITURES      FISCAL        FISCAL
                                        1997           (A)            1997           1997          1997
                                    -----------    -----------    ------------   -----------    -----------
<S>                                 <C>            <C>            <C>            <C>            <C>
Sales                               $ 1,460,805    $  (158,237)   $ 1,302,568    $    48,128    $    55,518
Cost of Sales                         1,084,691        (95,755)       988,936         30,603         39,194
                                    -----------    -----------    -----------    -----------    -----------
  Gross Margin                          376,114        (62,482)       313,632         17,525         16,324

Research and development expenses        44,907         (2,659)        42,248          1,601          4,253
Selling, general and
 administrative expenses                243,409        (36,539)       206,870          9,304          7,508
Merger, spinoff & nonrecurring
 charges                                   --             --             --            9,571           --
Asset impairment charge                  28,200           --           28,200           --             --
Gains on dispositions                      --             --             --             --           (2,379)
                                    -----------    -----------    -----------    -----------    -----------

Operating income (loss) from
 continuing operations                   59,598        (23,284)        36,314         (2,951)         6,942
Other income (expense)                   (5,572)            85         (5,487)        (2,356)          (494)
                                    -----------    -----------    -----------    -----------    -----------

Income (loss) from continuing
 operations before income taxes          54,026        (23,199)        30,827         (5,307)         6,448
Provision (benefit) for income
 taxes                                   23,381         (6,491)        16,890         (1,656)         1,608
                                    -----------    -----------    -----------    -----------    -----------

Income (loss) from continuing
 operations                         $    30,645    $   (16,708)   $    13,937    $    (3,651)   $     4,840
                                    ===========    ===========    ===========    ===========    ===========

Basic earnings per share from
 continuing operations              $      0.67    $     (0.37)   $      0.30
Diluted earnings per share from
 continuing operations              $      0.67    $     (0.37)   $      0.30

Weighted average shares of common
 stock outstanding:
  Basic                                  45,757         45,757         45,757
  Diluted                                45,898         45,898         45,898
</TABLE>


<TABLE>
<CAPTION>
                                       PRO FORMA
                                      ADJUSTMENTS           PRO FORMA
                                      -----------          -----------
<S>                                   <C>                  <C>
Sales                                 $      --            $ 1,406,214
Cost of Sales                               4,077(B)(H)      1,062,810
                                      -----------          -----------
  Gross Margin                             (4,077)             343,404

Research and development expenses            --                 48,102
Selling, general and
 administrative expenses                    6,902(G)(H)        230,584
Merger, spinoff & nonrecurring
 charges                                   (9,571)(K)             --
Asset impairment charge                   (28,200)(K)             --
Gains on dispositions                       2,379(K)              --
                                      -----------          -----------

Operating income (loss) from
 continuing operations                     24,413               64,718
Other income (expense)                     (8,913)(I)          (17,250)
                                      -----------          -----------

Income (loss) from continuing
 operations before income taxes            15,500               47,468
Provision (benefit) for income
 taxes                                      2,610(J)            19,452
                                      -----------          -----------

Income (loss) from continuing
 operations                           $    12,890          $    28,016
                                      ===========          ===========

Basic earnings per share from
 continuing operations                                     $      0.61
Diluted earnings per share from
 continuing operations                                     $      0.61

Weighted average shares of common
 stock outstanding:
  Basic                                                         45,757
  Diluted                                                       45,898
</TABLE>


The accompanying unaudited notes are an integral part of this pro forma
consolidated financial information.
<PAGE>   7
                                   EG&G, INC.
         NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION
                             (DOLLARS IN THOUSANDS)

Note 1) The purchase price was allocated to the estimated fair value of assets
acquired and liabilities assumed. The preliminary purchase price allocation is
based on the Company's estimates of respective fair values. The pro forma
consolidated balance sheet adjustments presented are as of December 16, 1998.
Some allocations are based on studies and independent valuations which are
currently being finalized. Management does not believe that the final purchase
price allocation will produce materially different results than those reflected
in the pro forma consolidated financial statements. Additionally, management
expects the Lumen restructuring plans to be finalized by the end of the year.
The components of the purchase price and preliminary allocation are as follows:

<TABLE>
<S>                                                                   <C>
Cash paid to Lumen for stock and options                              $ 162,050
Debt assumed                                                             74,388
Value of option rollover                                                  6,500
Deferred purchase price for subsidiary minority interest                  6,000
Acquisition costs                                                         3,925
                                                                      ---------
         Total consideration & acquisition costs                        252,863

Preliminary allocation of purchase price:
         Current assets                                                  66,829
         Property, plant & equipment                                     52,525
         Other assets                                                       430
         Identifiable intangible assets                                  11,800
         In-process research and development                              2,300
         Goodwill                                                       175,446
         Current liabilities                                            (50,097)
         Other liabilities                                               (6,370)
</TABLE>

(A) Represent adjustments to eliminate the results of operations of the Rotron
and Sealol Industrial Seals businesses that were sold by the Company on January
9, 1998 and April 1, 1998, respectively, as well as the related gains on
dispositions.

(B) Represents the write-up to fair value of Lumen work-in-process and finished
goods inventory as of the acquisition date. This amount will be charged to cost
of sales as the related inventory is sold and has been reflected as such in the
pro forma income statement for the year ended December 28, 1997.

(C) Includes approximately $11.8 million of acquired intangible assets
representing the fair value assigned to trademarks, trade names and patents by
an independent third party appraiser. Acquired intangible assets will be
amortized over their useful life of 10 years. Approximately $175,446 represents
the excess of consideration paid over the fair market value of Lumen's net
assets (goodwill) and will be amortized over 30 years. Such amount reflects an
incremental goodwill amount of $130,197 over the historical goodwill included in
Lumen's balance sheet as of September 30, 1998.

(D) Reflects the elimination of Lumen's historical equity accounts.
Additionally, the adjustment to retained earnings includes (a) the fair value of
Company's options issued in exchange for Lumen options totaling $6.5 million and
(b) $2.3 million that was allocated to in-process research and development for
projects that had not reached technological feasibility as of the acquisition
date and for which no alternative use existed. The estimated fair value was
based on a risk-adjusted cash flow and was determined by an independent third
party appraiser. This amount was expensed as a nonrecurring, non-tax deductible
charge upon consummation of the acquisition and has been reflected as a
reduction to retained earnings. The in-process research and development has not
been included in the pro forma combined income statements due to its
nonrecurring nature.
<PAGE>   8
(E) Includes adjustments to accrue transaction costs, record deferred taxes
resulting from purchase accounting and reflect the fair value of accrued
liabilities as of the acquisition date. Approximately $6 million represents
deferred purchase price related to minority ownership in a Lumen subsidiary.

(F) Represents the estimate of restructuring charges related to Lumen to be
incurred in connection with the acquisition. The restructuring plans include
initiatives to integrate the operations of the Company and Lumen, consolidate
duplicate facilities and reduce overhead. Management is in the process of
finalizing its restructuring plans related to Lumen, and accordingly, the
amounts recorded are based on management's current estimate of those costs.
Management expects that most of the restructuring actions related to the plan
will be completed within the next year.

(G) Includes additional amortization related to goodwill and acquired intangible
assets amortization as follows:

<TABLE>
<CAPTION>
                                                          12/97            9/98
<S>                                                      <C>              <C>
Goodwill                                                 $5,848           $4,386
Acquired intangibles                                      1,180              885
                                                         ------           ------
    Total amortization                                    7,028            5,271
Historical amortization                                     500              655
                                                         ------           ------
    Pro forma adjustment                                 $6,528           $4,616
                                                         ------           ------
</TABLE>

(H) Represents the write-up to fair value of Lumen property, plant & equipment
as of the acquisition date. The pro forma consolidated income statements include
additional depreciation expense related to these write-ups of $873 and $487 for
cost of sales and $374 and $209 for selling, general and administrative expenses
for the fiscal year ended December 28, 1997 and nine months ended September 27,
1998, respectively.

(I) Reflects $162,050 of cash paid to Lumen for stock and options and
incremental interest expense. The Company has currently financed this amount
with available cash and short-term debt consisting of commercial paper
borrowings with a weighted-average interest rate of 5.5% at year end. A 1/8 of
one percent change in the base rate would change annual interest expense by
approximately $203. The Company intends to refinance the outstanding debt with
fixed rate debt during fiscal 1999.

(J) Income tax adjustments have been calculated using estimated statutory income
tax rates. The primary difference between the provision calculated at statutory
rates and the amount reflected in the pro forma adjustments column for the
periods presented is attributable to nondeductible goodwill related the
acquisition as well as certain nondeductible elements in the various historical
non-recurring charges described in Note K below. The pro forma consolidated
provision for income taxes may not represent amounts that would have resulted
had the Company and Lumen filed consolidated income tax returns during the
periods presented.

(K) Historical nonrecurring charges related to restructuring, asset impairments
and merger/spinoff costs have been eliminated for purposes of the pro forma
consolidated income statements.

(L) On February 16, 1999, the Company paid $15.5 million to retire the
convertible subordinated notes. These notes were retired at a premium, and the
payment was funded through additional commercial paper borrowings. Such
retirement has not been reflected in this pro forma financial information.


 
<PAGE>   9

(c)      Exhibits

         Exhibit 2 - Agreement and Plan of Merger dated as of October 21, 1998
         by and among EG&G, Inc., Lighthouse Weston Corp. and Lumen
         Technologies, Inc. (incorporated by reference from Exhibit (c)(1) to
         Schedule 14D-1 filed by the Company with the Securities and Exchange
         Commission on October 27, 1998).

         Exhibit 22.1 - Consent of PriceWaterhouseCoopers LLP, Independent
         Accountants.

         Exhibit 22.2 - Consent of Arthur Andersen LLP, Independent Accountants.

         Exhibit 99.1 - Lumen Technologies, Inc. (formerly BEC Group, Inc.)
         Financial Statements as of December 31, 1997 and 1996 and for each of
         the three years in the period ended December 31, 1997.

         Exhibit 99.2 - ILC Technology, Inc. Financial Statements as of
         September 27, 1997 and September 28, 1996 and for each of the three
         years in the period ended September 27, 1997.



                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                     EG&G, Inc.


Date: March 9, 1999                                    By: /s/ Murray Gross
      -------------                                        ---------------------
                                                           Senior Vice President



<PAGE>   1

                                                                   Exhibit 22.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS



We hereby consent to the incorporation by reference in the Prospectuses
constituting part of the Registration Statements on Form S-3 (Nos. 333-71069 and
33-59675) and in the Registration Statements on Form S-8 (Nos. 2-98168,
33-36082, 33-35379, 33-49898, 33-57606, 33-54785, 33-62805, 333-8811, 333-32059,
333-32463, 333-70977, 333-50953, 333-56921, 333-58517, 333-61615, 333-65367,
333-69115) of EG&G, Inc. of our report dated April 9, 1998, relating to the
consolidated financial statements of Lumen Technologies, Inc. (formerly BEC
Group, Inc.), which are included in the Current Report on Form 8-K/A of EG&G,
Inc. dated February 26, 1999.



/s/ PRICEWATERHOUSECOOPERS LLP
- ------------------------------
PRICEWATERHOUSECOOPERS LLP

Dallas, Texas
March 9, 1999


<PAGE>   1



                                                                   Exhibit 22.2

                       CONSENT OF INDEPENDENT ACCOUNTANTS



As independent  public  accountants,  we hereby consent to the use of our report
dated  December 1, 1997  covering the  historical  financial  statements  of ILC
Technology,  Inc.  included  in this  Form  8-K/A  and to the  incorporation  by
reference of our report into Registration  Statements  previously filed by EG&G,
Inc. on Form S-8, File No. 2-98168; Form S-8, File No. 33-36082;  Form S-8, File
No.  33-35379;  Form S-8, File No. 33-49898;  Form S-8, File No. 33-57606;  Form
S-8,  File No.  33-54785;  Form  S-8,  File No.  33-62805;  Form  S-8,  File No.
333-8811; Form S-8, File No. 333-32059;  Form S-8, File No. 333-32463; Form S-8,
File No. 333-70977;  Form S-8, File No. 333-50953; Form S-8, File No. 333-56921;
Form S-8, File No. 333-58517;  Form S-8, File No. 333-61615;  Form S-8, File No.
333-65367;  Form S-8, File No.  333-69115;  Form S-3, File No. 33-59675 and Form
S-3, File No. 333-71069.



/s/ ARTHUR ANDERSEN LLP
- ------------------------
ARTHUR ANDERSEN LLP

San Jose, California
March 9, 1999


<PAGE>   1
                                                                    Exhibit 99.1

LUMEN TECHNOLOGIES, INC. (FORMERLY BEC GROUP, INC.) FINANCIAL STATEMENTS

REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and Stockholders of Lumen Technologies, Inc. (formerly
BEC Group, Inc.)

In our opinion, the accompanying consolidated balance sheets and the related
consolidated statements of operations, of comprehensive income (loss), of
stockholders' equity and of cash flows present fairly, in all material
respects, the financial position of Lumen Technologies, Inc. (formerly BEC
Group, Inc.) and its subsidiaries at December 31, 1997 and 1996, and the
results of their operations and their cash flows for each of the three years
in the period ended December 31, 1997, in conformity with generally accepted
accounting principles. These financial statements are the responsibility of
the Company's management; our responsibility is to express an opinion on these
financial statements based on our audits. We conducted our audits of these
statements in accordance with generally accepted auditing standards which
require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for the opinion expressed above.

As discussed in Note 1, on March 11, 1998, the Company distributed the stock
of its subsidiary, Bolle Inc., to the Company's stockholders and on March 12,
1998 merged with ILC Technology, Inc.

PRICE WATERHOUSE LLP
Dallas, Texas
April 9, 1998


<PAGE>   2
                 LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                           CONSOLIDATED BALANCE SHEETS
                             (AMOUNTS IN THOUSANDS)
<TABLE>
<CAPTION>
                                                                                                December 31,
                                                                                         --------------------------
                                                                                           1997             1996
                                                                                         --------         ---------
<S>                                                                                    <C>               <C>   
ASSETS
Current assets:
   Cash and cash equivalents                                                            $     762           $   2,164
   Trade receivables, less allowance for doubtful accounts of $586 and $503                10,214               7,280
   Inventories                                                                              9,534               9,317
   Investment in and net receivables from discontinued operations (Note 3)                 51,567              11,167
   Other current assets                                                                     6,094               3,651
                                                                                        ---------           ---------
      Total current assets                                                                 78,171              33,579
Property and equipment, net                                                                13,763              13,114
Goodwill, net                                                                              12,138              11,372
Intangible assets, net                                                                      1,225               1,296
Equity in and notes receivable from affiliated companies                                    8,773              11,435
Other assets                                                                                5,619               4,275
                                                                                        ---------           ---------
      Total assets                                                                      $ 119,689           $  75,071
                                                                                        =========           =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
   Short-term debt and current maturities of long term debt                             $  25,458           $  17,645
   Accounts payable                                                                         4,891               2,858
   Accrued compensation                                                                     1,390               2,134
   Other accrued expenses                                                                  12,095               8,557
                                                                                        ---------           ---------
      Total current liabilities                                                            43,834              31,194
Long-term debt                                                                             31,349               3,597
Convertible subordinated notes                                                             23,742              21,922
Other long-term liabilities                                                                 8,307              10,754
                                                                                        ---------           ---------
      Total liabilities                                                                   107,232              67,467
                                                                                        ---------           ---------

Commitments and contingencies
Mandatorily redeemable preferred stock--par value $1; 500 shares authorized;
    10 issued and outstanding                                                               9,294
                                                                                        ---------
Stockholders' equity:
   Common stock--par value $.01; 50,000 shares authorized; 8,815 issued; 8,813
    and 8,857 outstanding                                                                      88                  88
   Additional paid-in capital                                                              28,743              28,791
   Treasury stock - 2 and 58 shares at cost                                                   (17)               (557)
   Accumulated deficit                                                                    (25,651)            (20,718)
                                                                                        ---------           ---------
      Total stockholders' equity                                                            3,163               7,604
                                                                                        ---------           ---------
      Total liabilities and stockholders' equity                                        $ 119,689           $  75,071
                                                                                        =========           =========
</TABLE>

         See accompanying notes to consolidated financial statements.

<PAGE>   3
                 LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                  (AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
                                                                                           For the year ended December 31,
                                                                                     ---------------------------------------------
                                                                                         1997            1996           1995
                                                                                       --------        --------        -------
<S>                                                                                   <C>               <C>            <C>   
Continuing operations:
Net sales                                                                             $ 48,128           $ 42,574        $ 41,244
Costs and expenses:
   Costs of sales                                                                       30,603             25,676          23,725
   Selling, general and administrative expense                                          10,905             10,020          13,820
   Special charges and spinoff expenses                                                  9,571                              5,237
   Interest expense                                                                      3,458              2,942           4,087
   Other income, net                                                                    (1,102)            (1,378)         (3,337)
                                                                                      --------           --------        --------
      Total costs and expenses                                                          53,435             37,260          43,532
Income (loss) from continuing operations before income taxes                            (5,307)             5,314          (2,288)
Provision (benefit) for incomes taxes from continuing operations                        (1,656)             1,870          (1,339)
                                                                                      --------           --------        --------
Income (loss) from continuing operations                                              $ (3,651)          $  3,444        $   (949)
                                                                                      --------           --------        --------
Discontinued operations (Note 3):
Income (loss) from operations of the Prescription Eyewear Business, Foster            $ (1,282)          $  4,302        $ (5,811)
Grant Group and Bolle (less applicable taxes of $(2,020), $384 and $1,139 in
1997, 1996 and 1995, respectively)

Net gain on the sales of the Prescription Eyewear Business, and Foster Grant
Group net of phase out losses of $2,902
                                                                                                           75,010
                                                                                      --------           --------        --------
Income (loss) from discontinued operations                                            $ (1,282)          $ 79,312        $ (5,811)
                                                                                      --------           --------        --------
Net income (loss)                                                                     $ (4,933)          $ 82,756        $ (6,760)
Basic earnings (loss) per share:
   From continuing operations                                                         $  (0.44)          $   0.40        $  (0.12)
   From discontinued operations                                                          (0.15)              9.29           (0.77)
                                                                                      --------           --------        --------
                                                                                      $  (0.59)          $   9.69        $  (0.89)
                                                                                      --------           --------        --------
Basic EPS weighted average shares outstanding                                            8,803              8,537           7,620

Diluted earnings (loss) per share:
    From continuing operations                                                        $  (0.44)          $   0.40        $  (0.12)
    From discontinued operations                                                         (0.15)              9.22           (0.77)
                                                                                      --------           --------        --------
                                                                                      $  (0.59)          $   9.62        $  (0.89)
                                                                                      --------           --------        --------
Diluted EPS weighted average shares outstanding                                          8,803              8,600           7,620
</TABLE>


          See accompanying notes to consolidated financial statements.


<PAGE>   4
                LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                   STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
                            (AMOUNTS IN THOUSANDS)


<TABLE>
<CAPTION>
                                                                  For the year ended December 31
                                                       --------------------------------------------------------
                                                            1997                1996                  1995
                                                       --------------      --------------       ---------------
<S>                                                      <C>                  <C>                  <C>      
Net income (loss)                                        $ (4,933)            $ 82,756             $ (6,760)
Foreign currency translation adjustments                     (462)                                       26
Reclassification adjustment - (before taxes)                                        77
                                                        ---------            ---------            ---------
Comprehensive income (loss) before tax                     (5,395)              82,833               (6,734)
Other comprehensive income tax effect                         197                   (2)                  (9)
                                                        ---------            ---------            ---------
Comprehensive income (loss)                              $ (5,198)            $ 82,831             $ (6,743)
                                                        =========            =========            =========
</TABLE>


          See accompanying notes to consolidated financial statements
<PAGE>   5
                 LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
              FOR THE YEARS ENDED DECEMBER 31, 1997, 1996 AND 1995
                             (AMOUNTS IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                                        ADDITIONAL    RETAINED
                                            ISSUED COMMON       TREASURY    COMMON       PAID-IN      EARNINGS       TREASURY
                                                 SHARES          SHARES     STOCK        CAPITAL      (DEFICIT)        STOCK
                                            -------------       --------  ------      -----------    ---------      --------
<S>                                          <C>                <C>       <C>         <C>            <C>          <C>     
1995:
Balance - December 31, 1994                      7,268            49      $     72      $105,001     $  7,385      $ (1,365)
   Shares issued for acquisitions                   79                           1         2,845
   Shares issued through public offering,
     net of expenses                               589                           6        22,030
   Exercise of stock options                        79                           1         1,412
   Other issuances of common stock                  10                                       506
   Net loss                                                                                            (6,760)
                                              --------      --------      --------      --------     --------      --------
Balance - December 31, 1995                      8,025            49            80       131,794          625        (1,365)

1996:
   Exercise of stock options                       126                           1         2,326
   Other issuances of common stock                  66                                     1,567
   Cancel treasury stock                           (49)          (49)                     (1,365)                     1,365
   Repurchases of treasury stock                                  58                                                   (557)
   Dividend to stockholders                                                             (125,972)     (104,099)
   Conversion of 8% Convertible Notes
    due 2001                                       647                           7        20,441
    Net income                                                                                          82,756
                                              --------      --------      --------      --------     ---------      --------
Balance - December 31, 1996                      8,815            58            88        28,791      (20,718)         (557)

1997:
   Exercise of stock options                                     (84)                        (48)                       789
   Repurchase of treasury stock                                   28                                                   (249)
   Net loss                                                                                            (4,933)
                                              --------      --------      --------      --------     --------      --------
Balance - December 31, 1997                      8,815             2      $     88      $ 28,743     $(25,651)     $    (17)
                                              ========      ========      ========      ========     ========      ========
</TABLE>


         See accompanying notes to consolidated financial statements.


<PAGE>   6
                     LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                          CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (AMOUNTS IN THOUSANDS)
<TABLE>
<CAPTION>
                                                                                     FOR THE YEAR ENDED DECEMBER 31,
                                                                              ----------------------------------------------
                                                                                 1997              1996              1995
                                                                              ----------        ----------        ----------
<S>                                                                           <C>              <C>              <C>       
Cash flows from operating activities:
Income (loss) from continuing operations                                      $  (3,651)       $   3,444        $    (949)
Adjustments to reconcile income (loss) to net cash provided
(used) by operating activities:
Special charges and spinoff expenses, net of payments                             9,571                             4,120
Depreciation and amortization                                                     1,477            1,105            1,234
Bad debt expense                                                                    163               26              280
Loss (gain) on sale of property and equipment                                                        414             (316)
Other                                                                                                                  15
Changes in current assets and liabilities (net of effect of companies
acquired):
Trade receivables                                                                (3,017)             (89)          (2,201)
Inventories                                                                        (217)          (1,371)             256
Other assets                                                                        723           (2,054)          (3,529)
Accounts payable                                                                  2,033              356            2,383
Accrued expenses and other                                                       (1,972)               3           (4,663)
Cash provided (used) by discontinued operations                                     144            6,853           (9,122)
                                                                              ---------        ---------        ---------
Net cash provided (used) by operating activities                              $   5,254        $   8,687        $ (12,492)
                                                                              ---------        ---------        ---------
Cash flows from investing activities:
Cash expended in acquisitions, net of cash received                              (5,164)                           (3,865)
Capital expenditures                                                             (1,372)            (618)          (1,619)
Notes receivable from affiliates                                                   (815)
Proceeds from sale of fixed assets                                                                   155            3,648
Cash provided (used) by discontinued operations                                 (33,848)         276,112          (36,887)
                                                                              ---------        ---------        ---------
Net cash provided (used) by investing activities                              $ (41,199)       $ 275,649        $ (38,723)
                                                                              ---------        ---------        ---------
Cash flows from financing activities:
Net proceeds from (payments for) issuance of long-term debt                      27,350          (15,364)           3,010
Proceeds (payments) from revolving credit lines and short term debt               7,813          (45,000)          (8,938)
Proceeds from issuance of common stock                                              492            1,944           23,569
Cash dividend to stockholders                                                                   (230,071)
Cash provided (used) by discontinued operations                                  (1,112)           2,264           26,198
                                                                              ---------        ---------        ---------
Net cash provided (used) by financing activities                              $  34,543        $(286,227)       $  43,839
                                                                              ---------        ---------        ---------
Net decrease in cash                                                          $  (1,402)       $  (1,891)       $  (7,376)
Cash and cash equivalents at beginning of year                                    2,164            4,055           11,431
                                                                              ---------        ---------        ---------
Cash and cash equivalents at end of year                                      $     762        $   2,164        $   4,055
                                                                              =========        =========        =========
</TABLE>
                                  (Continued)


<PAGE>   7
                 LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                             (AMOUNTS IN THOUSANDS)
                                   (CONTINUED)

<TABLE>
<CAPTION>
                                                                    For the year ended December 31
                                                             --------------------------------------------
                                                               1997              1996              1995
                                                             --------          --------         ---------
<S>                                                           <C>               <C>               <C>   
Supplemental disclosures of cash flow information:
   Interest paid                                              $2,167            $6,710            $9,100
   Income taxes paid                                          $  484            $2,581            $  910
</TABLE>



         Noncash transactions:
1997

         -        Recorded $1,835 of interest on convertible subordinated
                  notes which is accrued until conversion, redemption or
                  maturity.

         -        The acquisition of Bolle France included in discontinued
                  operations was consummated during the year. The acquisition
                  was funded with cash, equity and debt. The fair values of
                  the assets and liabilities at the date of acquisition were
                  as follows:
<TABLE>

<S>                                               <C>     
Cash                                              $  1,294
Accounts receivable                                  9,441
Inventories                                          6,167
Other current assets                                   388
Property and equipment                               3,949
Goodwill                                            22,642
Trademark                                           40,000
Other assets                                           181
Short-term debt                                       (175)
Accounts payable and accrued liabilities            (9,756)
Other long-term liabilities                        (15,896)
</TABLE>


1996

         -        $20,448 of Benson convertible notes were converted into
                  equity during 1996 in conjunction with the Essilor Merger.

         -        $500 of notes receivable from Superior Vision Services, Inc.
                  ("SVS") was forgiven during 1996.

         -        Recorded $1 million of non-interest bearing convertible
                  preferred stock as partial consideration on the sale of FGG.

                                  (Continued)

<PAGE>   8
                LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (AMOUNTS IN THOUSANDS)
                                  (CONTINUED)
1995

         -        Recorded a $1.9 million non-interest bearing convertible
                  note receivable in exchange for notes and trade receivables.

         -        Certain business combinations and divestitures were
                  consummated during the year. The acquisitions were funded
                  through a combination of cash, equity and debt. The fair
                  values of the assets and liabilities at the dates of
                  acquisition were allocated as follows: Accounts receivable
                  $2,888, Property and equipment $622, Goodwill $13,841,
                  Intangible assets $1,350, Other assets $358, Accounts
                  payable and accrued liabilities $(1,840), and Other
                  long-term assets and liabilities $2,416.


         See accompanying notes to consolidated financial statements.
<PAGE>   9
                LUMEN TECHNOLOGIES, INC. F/K/A BEC GROUP, INC.
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    (AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA, UNLESS OTHERWISE NOTED)

NOTE 1 -- SPINOFF AND MERGER SUBSEQUENT TO YEAR END

         On March 11, 1998, the Company distributed its subsidiary, Bolle Inc.
("Bolle"), to its stockholders via a spinoff (the "Spinoff"). In the Spinoff,
Company stockholders received one share of Bolle for every three shares of
Company common stock. In conjunction with the Spinoff, the Company and Bolle
entered into a Management Services Agreement and a Bill of Sale and Assignment
Agreement (the "Contribution Agreement"). The Management Services Agreement
provides management services to Bolle for an agreed fee. In accordance with
the Contribution Agreement, (i) the Company assigned to Bolle all of the
Company's assets other than the assets related to the ORC Technologies, Inc.
("ORC") Business (as defined in the Contribution Agreement ) and certain other
specific assets retained by the Company; and (ii) Bolle will assume all of the
Company's liabilities prior to the Spinoff other than those related to the ORC
Business and certain specific liabilities.

         On March 12, 1998, the Company (through its wholly-owned subsidiary,
BILC Acquisition Corp.) completed its merger with ILC Technology, Inc. (the
"ILC Merger"). Under the terms of the agreement, ILC shareholders received
4.4084 shares of the company's Common Stock (or 2.2042 shares, after giving
effect to a one-for-two reverse split of the Company's Common Stock) for each
share of ILC Common Stock outstanding. In conjunction with the ILC Merger, the
Company changed its name to Lumen Technologies, Inc. The effect of the
one-for-two reverse split has been retroactively presented in these financial
statements.

         The accompanying consolidated financial statements (i) reflect the
continuing operations of ORC; (ii) reflect Bolle net assets as "Investment in
and net receivables from discontinued operations" and Bolle's results of
operations as discontinued for all periods presented; (iii) do not reflect the
ILC Merger and (iv) do not reflect the disposition of certain assets and
liabilities pursuant to the Contribution Agreement.

         On a proforma basis, had the above transactions occurred at December
31, 1997, the Company's total assets and stockholders' equity would have been
approximately $130 million (unaudited) and $35 million (unaudited),
respectively.

NOTE 2 -- BUSINESS

Business

         During the periods presented, Lumen Technologies, Inc. ("Lumen" or
the "Company") had one core business, ORC which manufactures and markets
specialty lighting, electronic and electroformed products to a diverse
customer base. The evolution of the Company was accomplished through a series
of acquisitions and divestitures which were consummated during the period from
October 1992 through December 1997 (Notes 3 and 6). The name was changed from
BEC Group, Inc. in conjunction with the Spinoff (Note 1) and the ILC Merger
(Note 1) in March 1998.

<PAGE>   10
NOTE 3 -- DISCONTINUED OPERATIONS

Bolle Inc.

         On March 11, 1998, the Company completed the Spinoff of Bolle to the
Company's stockholders (Note 1). Accordingly, the accompanying financial
statements reflect the results of operations of Bolle as discontinued
operations for all periods presented but do not reflect the transfer of the
other assets and liabilities to Bolle Inc. at the time of the Spinoff in
conjunction with the Contribution Agreement. After the Spinoff, the
"Investment in and net receivables from discontinued operations" caption will
be reduced to zero and will be accompanied by a corresponding entry to reduce
paid in capital.

Foster Grant Group and Dallas Corporate Headquarters

         On December 12, 1996, the Company sold to Foster Grant Holdings, Inc.
("Holdings") all of the issued and outstanding shares of capital stock of the
entities comprising the Foster Grant Group ("FGG"). At closing, the Company
received $29 million in cash and 100 shares of non-voting preferred stock with
a maximum redemption value of $6 million (the "Preferred Stock"). By agreement
with Accessories Associates, Inc. ("AAi"), the Company may, at its option,
exchange the Preferred Stock for shares of AAi common stock if AAi completes
an initial public offering ("IPO") at any time within three (3) years of
closing. Upon any such exchange, the Company will receive the number of shares
of AAi common stock equal to $6 million divided by 85% of the IPO offering
price, as set forth in the AAi final IPO prospectus. Any such shares of AAi
common stock will not be registered for resale under federal securities laws,
but will bear "piggyback" registration rights. If the Preferred Stock is not
converted, it will be redeemed by Foster Grant Holdings, Inc. ("Holdings") on
or before February 28, 2000 for up to $6 million, based on FGG's net sales
for the year ending December 31, 1999. The cash consideration was used to pay
down the company's credit facility and pay transaction expenses. The results
of operations for FGG and the Dallas Corporate Headquarters, which was closed
in connection with the sale of FGG, are presented as discontinued operations
of the Company. The assets of FGG, net of liabilities, are presented as
investment in discontinued operations at December 31, 1995. A loss of $26.1
million including transaction expenses and phase-out losses, net of taxes was
recorded on the sale. All rights, liabilities and obligations of the Company
with respect to the Preferred Stock and/or agreement by and between the
Company, AAi Holdings and/or FGG was assigned to, and assumed by, Bolle in
connection with the Spinoff.

Prescription Eyewear Business

         On May 3, 1996, Benson Eyecare Corporation (the predecessor of the
Company) ("Benson"), the Company, Essilor International, S.A. ("Essilor"),
Essilor of America, Inc. ("Essilor of America"), a wholly owned subsidiary of
Essilor and Essilor Acquisition Corporation, Inc. ("Essilor Sub"), a wholly
owned subsidiary of Essilor of America, entered into an Agreement and Plan of
Merger, as amended pursuant to which Essilor purchased Benson and the Omega
Group, Benson's wholesale optical laboratory business (the "Essilor Merger").
Benson also entered into an Asset Purchase Agreement, pursuant to which
Benson's lens manufacturing business, Orcolite, was purchased by the Monsanto
Company (the "Asset Sale"). The Omega Group and Orcolite comprised the
Prescription Eyewear Business of Benson. In connection with the Spinoff, Bolle
will agree to indemnify the Company against any and all liabilities, damages,
costs or other expenses arising in connection with the Essilor transaction,
except to the extent arising as a result of the ORC Business.

         Pursuant to the Essilor Merger, each outstanding share of Benson
common stock was exchanged for $6.60 in cash and one share of the Company's
Common Stock was received for every two shares of Benson Common Stock. Upon
consummation of the Essilor Merger, the equity interest in Benson of its
stockholders ceased and Benson became a wholly owned subsidiary of Essilor of
America. Also upon consummation of the Essilor Merger, the Company became a
registrant whose common shares are traded on the NYSE.


<PAGE>   11
         For accounting purposes, the company was considered the continuing
entity. Accordingly, in substance, the Merger and Asset Sale were considered
to be a sale of Omega and Orcolite by the Company to Essilor and Monsanto
Company, respectively. Upon approval of the Essilor Merger, Benson's
historical consolidated financial statements, adjusted for the sale of the
Prescription Eyewear business, became the historical financial statements of
the Company. The gain on the sale of these businesses of $100.7 million and
the results of operations for these businesses are presented as discontinued
operations of the Company. The cash merger consideration is treated as a
dividend by the Company. The assets of the discontinued operations, net of
liabilities, are presented as investment in discontinued operations at
December 31, 1995. The accounting treatment of the Essilor Merger and Asset
Sale differed from the legal and federal income tax treatment.

         During the third quarter of 1996, the final Closing Balance Sheet for
the sale of Omega was agreed upon by the Company and Essilor. According to the
terms of the Essilor Merger, a purchase price adjustment of $2.1 million was
paid to Essilor on October 3, 1996, decreasing the gain on the sale.
Additionally, Essilor and the Company agreed to settle the Contingent
Valuation Right (the "CVR") early for cash of $2.2 million payable by the
Company to Essilor in January 1997. Accordingly, the gain on the sale
increased by approximately $2.4 million. The net result of the described
adjustments, in addition to the adjustment of certain accruals relating to the
Merger, was a $791 incremental gain on the sale of the Prescription Eyewear
Business recorded in discontinued operations in the third quarter.

         Summarized information on the combined discontinued operations,
excluding the net gain on the transactions follows. The amounts represent the
operating results of FGG, the Prescription Eyewear Business and Bolle Inc.
business through their respective measurement dates.

<TABLE>
<CAPTION>
                                                       FOR THE YEAR ENDED
                                            ------------------------------------------
                                               1997            1996           1995
                                            ---------       ----------      ---------
<S>                                       <C>                 <C>            <C>     
Net sales                                  $  32,160           $ 125,987     $ 260,591
Income (loss) before income taxes             (3,369)              4,686        (4,672)
Income tax expense (benefit)                  (2,020)                384         1,139
Minority interests                               (67)
                                           ---------           ---------     ---------
Net income (loss)                          $  (1,282)          $   4,302     $  (5,811)
                                           =========           =========     =========
</TABLE>


         Pursuant to the Essilor Merger, all Benson stock options were
canceled. Continuing Company option holders received cash and new options in
exchange for their Benson options. Option holders from discontinued operations
received cash and the Company stock in exchange for their Benson options.

NOTE 4 -- SPECIAL CHARGES AND SPINOFF EXPENSES

         The Company's special charges and spinoff expenses of $9.6 million
for the year ended December 31, 1997 include the following items:

         (i)      A $6.2 million charge to reflect the impairment of the
                  Company's long term investment in Eyecare Products plc
                  ("Eyecare") (Note 10). This investment has historically been
                  accounted for under the equity method reflecting the
                  Company's percentage shareholding and the long term nature
                  of this investment. In connection with the Spinoff and the
                  transfer of the Eyecare shares to Bolle, the Company has
                  reassessed Eyecare's operating performance and market
                  performance and accordingly has written down its investment
                  in Eyecare to market value at December 31, 1997.


<PAGE>   12
         (ii)     A $2.2 million charge to reflect the impairment of the
                  Sterling Vision, Inc. Convertible Subordinated Note Due 2015
                  due to Sterling's recent operating performance and negative
                  operating cash flows.

         (iii)    Spinoff expenses of $1.2 million for expenses relating to
                  the distribution of Bolle Inc. See Note 1.

         The Company's special charges of $5.2 million for the year 1995
included primarily: (i) a $4.3 million charge to reflect the impairment of
certain notes receivable and trade accounts receivable from OCA Acquisition,
Inc., d/b/a/ Optical Corporation of America ("OCA") prior to the exchange of
such assets for a non-interest bearing convertible note receivable from
Sterling Vision, Inc.; (ii) the write-off of $500 of deferred financing costs
in connection with a change in the Company's banking syndicate in September
1995. None of the above items relate to the operations of the ORC business.

NOTE 5 -- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

         The consolidated financial statements include the accounts of the
Company and its majority owned subsidiaries over which the Company asserts
control. Investments in less than 50% owned affiliates are accounted for by
the equity method, investments in less than 20% owned affiliates are accounted
for by the cost method (Note 10). All significant intercompany transactions,
profits and accounts have been eliminated in consolidation.

Cash Equivalents

         Cash equivalents include all temporary cash investments with original
maturities of three months or less. The carrying value is equal to market
value.

Revenue Recognition

         The Company recognizes revenue upon shipment or delivery of products.

Concentration of Credit Risk and Major Customers

         The Company is not subject to significant concentrations of credit
risk. However, trade receivables arising from sales to customers are not
collateralized and as a result management continually monitors the financial
condition of these customers to reduce the risk of loss. Notes receivable
relate to the divestiture of certain businesses and related assets in 1995 and
1994. The carrying values of notes receivable approximate fair value.

Inventories

         Inventories, which consist primarily of raw materials and finished
goods held for resale, are stated at the lower of cost or market value and
determined on a first-in-first-out basis.

Warranties

         Certain sales are subject to warranty against defects in material and
workmanship for varying periods. The Company provides for such potential
future costs at the time the sales are recorded.

<PAGE>   13
Property and Equipment

         Property and equipment are stated at cost. Additions and improvements
are capitalized. Maintenance and repairs are expensed as incurred.
Depreciation is computed on a straight line basis for financial reporting
purposes, and on an accelerated basis for tax purposes, over the estimated
useful lives of the assets. Useful lives range from 3 to 5 years for office
equipment to 30 years for buildings. Asset cost and accumulated depreciation
amounts are removed for dispositions and retirements, with resulting gains and
losses reflected in earnings.

Goodwill and Intangible Assets

         Goodwill represents the excess cost over the fair value of net assets
acquired in business combinations accounted for under the purchase method.
Intangible assets consist principally of trademarks and other identifiable
intangible assets.

         Goodwill and intangible assets are amortized on a straight line basis
over estimated useful lives which approximate 40 years for goodwill, 20 years
for trademarks, and from 3-10 years for other identifiable intangibles. At
each balance sheet date, the Company evaluates the realizability of goodwill
and intangible assets based upon expectations of undiscounted cash flows of
each subsidiary having a significant goodwill or intangible asset balance.
Should this review indicate that goodwill or intangible assets will not be
recoverable, the Company's carrying value of the goodwill or intangible assets
will be reduced by the estimated shortfall of discounted cash flows. Based
upon its most recent analysis, the Company believes that no material
impairment of goodwill or intangible assets exists.

Income Taxes

         Deferred income taxes are provided on the difference in basis of
assets and liabilities between financial reporting and tax returns using
enacted tax rates. A valuation allowance is recorded when realization of
deferred tax assets is not assured.

Investments in Affiliates

         Investments in affiliates owned less than 20% are carried on the
balance sheet according to the cost method. Investments in more than 20% owned
affiliates are carried on the balance sheet according to the equity method.

Earnings Per Share

         Basic earnings per share is computed by dividing net earnings or loss
available to common stockholders by the weighted average number of outstanding
shares of common stock. Diluted earnings per share includes weighted average
common stock equivalents outstanding during each year in the denominators,
unless the effect is anti-dilutive. Common stock equivalents consist of the
dilutive effect of common shares which may be issued upon exercise of stock
options, warrants or conversion of debt.

         In accordance with Securities and Exchange Commission Staff
Accounting Bulletin No. 98, the weighted average number of outstanding common
shares and common stock options is calculated based on the historical timing
of the common stock transactions. Also, the May 3, 1996 and March 12, 1998
reverse stock splits have been retroactively reflected in the Company's
financial statements.

<PAGE>   14
Reclassifications

         Certain amounts in the 1996 and 1995 financial statements have been
reclassified to conform with the 1997 presentation.

Estimates

         The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates.

NOTE 6 -- BUSINESS COMBINATIONS AND DIVESTITURES

1997 BUSINESS COMBINATIONS

Bolle France

         On July 9, 1997, the Company acquired, in a transaction accounted for
as a purchase, all of the shares of Bolle France which included Bolle France
and several consolidated and unconsolidated subsidiaries, for a total purchase
price of approximately $58,235, comprised of cash of $31,000, BEC Series A
mandatorily redeemable preferred stock of $9,294, Bolle mandatorily redeemable
preferred stock of $11,055 and Bolle common stock of $3,302, as well as direct
acquisition costs of $3,595. Where such consideration was denominated in
French Francs, the July 10, 1997 exchange rate of 5.9197 was used to translate
to US Dollars.

Voltarc Technologies

                  On October 1, 1997, the Company expanded its interests in
the specialty lighting business. Pursuant to the terms of a Stock Purchase and
Option Agreement (the "Voltarc Purchase Agreement") dated as of October 1,
1997 among the Company, ORC, Voltarc and certain stockholders of Voltarc (the
"Voltarc Stockholders"), the Company and ORC acquired (a) 30% of the common
stock of Voltarc, for $1,800,000, (b) 12,000 shares of preferred stock of
Voltarc, convertible at ORC's option into approximately 10% of the total
number of shares of Voltarc issued and outstanding for $1,200,000 and (c) a
call option to acquire the remaining shares of capital stock of Voltarc from
the remaining Voltarc Stockholders in March 1999 if certain earnings
benchmarks are met. Pursuant to the Voltarc Purchase Agreement, the Voltarc
stockholders also received the right to put the remaining shares of Voltarc
common stock to the Company or ORC upon the occurrence of certain events. In
addition, ORC made available to Voltarc a subordinated revolving credit
facility in the amount of $800,000. The Company accounts for its investment in
Voltarc under the equity method. Voltarc is a manufacturer and marketer of
specialty lighting products.

1997 AND 1996 DIVESTITURES

         For a discussion of 1997 and 1996 divestitures see Note 3.


<PAGE>   15
1995 BUSINESS COMBINATION

Bolle America, Inc.

         Effective November 2, 1995, the Company acquired all of the
outstanding common stock of Bolle America, Inc. ("Bolle America") in exchange
for 3,265 shares of the Benson Common Stock, valued at $31 million. The
business combination was accounted for as a pooling of interests and
accordingly, the financial statements of Bolle America were combined with
those of the Company. The Company entered into employment, consulting and
noncompete agreements with the former president of Bolle America providing for
annual payments of $255 from 1996 through 2000. Bolle America's results are
included in discontinued operations.

1995 DIVESTITURES

         Effective September 15, 1995, the Company exchanged its interests in
notes receivable and trade accounts receivable from OCA for a non
interest-bearing convertible note receivable from Sterling Vision, Inc. (Note
4).

         Effective June 30, 1995, the Company sold 100% of the issued and
outstanding capital stock of Superior Eye Care for aggregate consideration of
$5 million. There was no gain or loss recorded on the transaction.

NOTE 7 -- INVENTORIES

         Inventories consist of the following at December 31:

<TABLE>
<CAPTION>
                            1997              1996
                          -------           --------
<S>                       <C>              <C>   
Raw materials             $ 4,604           $ 4,534
Work in progress            2,859             2,655
Finished goods              2,739             2,504
Reserves                     (668)             (376)
                          -------           -------
                          $ 9,534           $ 9,317
                          =======           =======
</TABLE>

NOTE 8 -- PROPERTY AND EQUIPMENT

         Property and equipment consists of the following at December 31:

<TABLE>
<CAPTION>
                                          1997              1996
                                       ---------          --------
<S>                                    <C>                <C>   
Land                                   $  1,632           $  1,631
Buildings                                10,458             10,401
Machinery and equipment                   3,775              3,224
Furniture and fixtures                      291                203
Leasehold improvements                       57                 42
Construction in progress                    603
                                       --------           --------
                                         16,816             15,501
Less accumulated depreciation            (3,053)            (2,387)
                                       --------           --------
Net property and equipment             $ 13,763           $ 13,114
                                       ========           ========
</TABLE>


<PAGE>   16
         Depreciation expense for the years ended December 31, 1997, 1996 and
1995 was $1,097, $748 and $742, respectively.

         Land and buildings totaling $6.1 million net of accumulated
depreciation are subject to operating leases. The minimum future rental income
is as follows:

<TABLE>

<S>                                               <C>   
1998                                              $1,257
1999                                                 762
2000                                                 494
2001                                                 494
Thereafter
                                              ----------
                                                  $3,007
                                              ==========
</TABLE>

NOTE 9 -- GOODWILL AND INTANGIBLE ASSETS

         Intangible assets and accumulated amortization consist of the
following at December 31:
<TABLE>
<CAPTION>
                                                1997               1996
                                              --------           --------
<S>                                           <C>                <C>     
Goodwill                                      $ 13,011           $ 11,939
Trademarks                                       1,482              1,498
Other identifiable intangible assets                __                (16)
                                              --------           --------
                                                14,493             13,421
Less accumulated amortization                   (1,130)              (753)
                                              --------           --------
                                              $ 13,363           $ 12,668
                                              ========           ========
</TABLE>

         Amortization expense for goodwill and intangible assets for the years
ended December 31, 1997, 1996 and 1995, was $380, $357 and $492, respectively.

NOTE 10 -- EQUITY IN AND NOTES RECEIVABLE FROM AFFILIATED COMPANIES

Eyecare Products plc

         The Company first invested in Eyecare Products plc in December 1993.
For the years ended December 31, 1997, 1996 and 1995, the Company recognized
equity earnings of $595, $275 and $525, respectively, on its investment in
Eyecare. The Company entered into an agreement, dated November 14, 1996, as
amended, with Lantis Eyewear Corporation ("Lantis"), whereby the Company sold
3,500 shares of Eyecare to Lantis and granted Lantis an option to acquire the
Company's remaining interest in Eyecare. Lantis did not exercise its December
1997 option as the operating performance of Eyecare was below Lantis'
expectations and its market price was below the option floor price. The
Company currently maintains a 23% interest in Eyecare. Due to the value
impairment and the Company's intention to dividend this investment to Bolle
according to the Contribution Agreement, this investment was written down to
market value at December 31, 1997 resulting in a special charge of $6.2
million.

<PAGE>   17
         Eyecare Products shares two common directors with the Company, and
the Company has a management agreement with Eyecare Products under which a
management fee is paid to the Company, not to exceed .5% of Eyecare Products
net sales. No management fee was charged in 1997. The Company recognized
management fee income of $100 and $300 during each of the years December 31,
1996 and 1995, respectively.

NOTE 11 -- CREDIT FACILITIES

Short-Term Debt

         Short-term debt consists of the following at December 31:

<TABLE>
<CAPTION>
                                                  1997             1996
                                                -------          -------
<S>                                             <C>              <C>    
Credit Agreement                                $23,282          $17,500
Current maturities of long-term debt              2,159              145
Other short term debt                                17               
                                                -------          -------
                                                $25,458          $17,645
                                                =======          =======
</TABLE>


Credit Agreement

         On April 3, 1996, the Company and certain of its subsidiaries entered
into a credit facility (the "Credit Agreement") with a syndicate of lenders
(the "Lenders"), led by NationsBank, N.A., ("NationsBank"). The Original
Credit Agreement, as amended effective December 12, 1996 and July 10, 1997,
provided for a $70 million revolving credit facility, which included a letter
of credit subfacility of $5 million, and two $15 million term facilities. The
interest rate applicable to the credit facilities will equal the Base Rate,
the Eurodollar Rate or the French Franc Libor Rate (each, as defined in the
Credit Agreement), as the Company may from time to time elect. The Base Rate
will generally be equal to the sum of (a) the greater of (i) the prime rate as
announced from time to time by NationsBank or (ii) the Federal Funds Rate plus
one-half percent (0.5%), and (b) a margin ranging from 0% to .375%, depending
upon the Company's satisfaction of certain financial criteria. The Eurodollar
Rate and the French Franc Libor Rate will generally be equal to the interbank
offered rate, as adjusted to give effect to reserve requirements, plus a
margin ranging from .625% to 1.625%, depending upon the Company's satisfaction
of certain financial criteria. A commitment fee of $175 was paid upon closing
the Credit Agreement in April 1996 and a commitment fee of $596 was paid upon
Closing of the July 10, 1997 amendment.

         At December 31, 1996, the Company had aggregate borrowing capacity
under the Credit Agreement of $25 million. During 1996, the weighted average
interest rate on borrowings under the facility was 7.1%, the average
outstanding balance was $42.3 million, and the maximum balance outstanding was
$68 million.

         At December 31, 1997, the Company had aggregate borrowing capacity
under the Credit Agreement of $70 million. During 1997, the weighted average
interest rate on borrowings under the facility was 6.7%, the average
outstanding balance was $35.4 million, and the maximum balance outstanding was
$53.4 million.

         On March 11, 1998, in conjunction with the ILC Merger and the
Spinoff, the Company and its subsidiaries (excluding Bolle) entered into a
Second Amended and Restated Credit Agreement (the "New Credit Agreement"). The
New Credit Agreement provides for a $40 million revolving credit facility,
which includes a letter of credit subfacility of $5 million, and a $30 million
term facility. The interest rate applicable to the facilities will equal the
Base Rate or the Eurodollar Rate (each, as defined in the New Credit
Agreement), as the Company may from time to time elect. The Base Rate will
generally be equal to the sum of (a) the greater of (i) the prime rate as
announced 

<PAGE>   18
from time to time by NationsBank or (ii) the Federal Funds Rate plus
one-half percent (0.5%), and (b) a margin ranging from 0% to 0.25%, depending
on the Company's satisfaction of certain financial criteria. The Eurodollar
Rate will generally be equal to the interbank offered rate, as adjusted, to
give effect to reserve requirements, plus a margin ranging from 0.875% to
1.75%, depending upon the Company's satisfaction of certain financial
criteria. Commitment and related fees of $420 were paid upon the closing of
the New Credit Agreement.

         At December 31, 1997, the Company was in compliance with all debt
covenants.

Long-Term Debt

         Long-term debt consists of the following at December 31:

<TABLE>
<CAPTION>
                                   1997               1996
                                 --------           -------
<S>                              <C>                <C>
Credit Agreement                 $ 29,987
Mortgage                            3,521           $  3,742
                                 --------           --------
                                   33,508              3,742
Less current maturities            (2,159)              (145)
                                 --------           --------
                                 $ 31,349           $  3,597
                                 ========           ========
</TABLE>


         Aggregate maturities of long-term debt are as follows:
<TABLE>

<S>                               <C>    
      1998                        $ 2,159
      1999                          5,175
      2000                          7,691
      2001                         10,210
      2002                          5,717
Thereafter                          2,556
                                  -------
                                  $33,508
                                  =======
</TABLE>

         The fair value of long term debt is estimated using incremental
borrowing rates currently available to the Company. The carrying value of
long-term debt approximates fair value.

Convertible Subordinated Notes

         On May 9, 1994, Benson completed a public offering of $40,950
Convertible Subordinated Notes, due 2001 with a coupon rate of 8% and a
conversion price of $9.056 per Benson share. In connection with the Essilor
Merger, holders of $40,896 Convertible Subordinated Notes due 2001 accepted a
Conversion and Exchange Agreement whereby they exchanged one-half of their
principal amount and a portion of accrued interest for new 8% Convertible
Notes due 2002 (the "New Notes"). The other half of their notes was converted
into Merger Consideration using a $7.90 conversion price. The New Notes accrue
interest semi-annually but do not pay interest until conversion, redeemption
or maturity. Accordingly, $2,723 of accrued interest is included in the
Convertible Subordinated Notes balance at December 31, 1997. Interest may be
paid in cash or in kind at the option of the Company. The conversion price for
the New Notes was $5.75. As of December 31, 1997, there were $21,019 New Notes
and $0 Benson Notes outstanding. The Company registered the New Notes with the
Securities and Exchange Commission effective January 28, 1997. Since December
31, 1997, $8,045 of New Notes have converted into BEC stock.

<PAGE>   19
Mortgage

         The Company has a $3,521 mortgage bearing interest at LIBOR plus 1.85
basis points, secured by land and buildings in Dallas, Texas, with monthly
principal and interest payments of $41 due through April 2001. Such payments
are paid using rental income from FGG which occupies the building. The
building and related mortgage were transferred to Bolle Inc. under the
Contribution Agreement. A contract to sell the property at a value in excess
of the mortgage valuation has been entered into.

NOTE 12 -- INCOME TAXES

         The Company accounts for income taxes under SFAS No. 109. "Accounting
for Income Taxes". SFAS No. 109 requires an asset and liability approach to
accounting for income taxes.

         Income (loss) before provision for income taxes consists of the
following for the periods ended:
<TABLE>
<CAPTION>
                                           DECEMBER 31,
                         ---------------------------------------------------
                               1997             1996              1995
                         ---------------    ------------     ---------------
<S>                      <C>                <C>              <C>     
U.S.                         $(9,766)          $85,010          $(6,960)
Foreign                        1,157
                         ---------------    ------------     ---------------
                             $(8,609)          $85,010          $(6,960)
                         ===============    ============     ===============
</TABLE>

         The provision (benefit) from income taxes consists of the following
for continuing and discontinued operations for the periods ended:

<TABLE>
<CAPTION>
                                                 1997             1996               1995
                                              ----------       ----------         ----------
<S>                                           <C>              <C>                <C>   
Continuing operations:
   Current:
      Federal                                   $1,177           $2,365             $(138)
      State and local                               67              141               (27)
   Deferred                                     (2,900)            (636)            (1,174)
                                              --------         --------            -------
                                               $(1,656)          $1,870            $(1,339)
                                              ========         ========            =======
</TABLE>

<TABLE>
<CAPTION>
Discontinued operations:                                1997            1996          1995
U.S.:                                                 --------         -------        ------
<S>                                                   <C>               <C>            <C> 
    Current                                          $(1,713)          $   623         $   719
    Deferred                                            (961)             (239)            420
Foreign:
    Current                                            1,803
    Deferred                                          (1,149)
                                                     -------           -------         -------
                                                     $(2,020)          $   384         $ 1,139
                                                     -------           -------         -------
Total provision (benefit) from income taxes          $(3,676)          $ 2,254         ($  200)
                                                     =======           =======         =======
</TABLE>

<PAGE>   20
         The Company's effective tax rates for continuing and discontinued
operations differ from the Federal statutory rate as follows:

<TABLE>
<CAPTION>
                                                      1997         1996         1995
                                                     ------       ------       ------
<S>                                                 <C>           <C>         <C>
Expected tax (benefit) at statutory rate            (35.0%)        35.0%       (35.0%)
State income taxes                                   (2.0%)         2.0%        (2.0%)
Provision to return adjustment                       (7.6%)
Effects of acquisitions and divestitures              4.7%        (32.9%)        4.2%
Valuation allowance                                                (1.6%)       16.9%
Goodwill amortization                                 3.0%          1.3%        10.9%
Other, net                                           (5.8%)        (1.1%)        2.1%
                                                    ------        ------       ------
                                                    (42.7%)         2.7%        (2.9%)
                                                    ======        =====        ======
</TABLE>

         Significant components of deferred income taxes for continuing and
discontinued operations are as follows at December 31:
<TABLE>
<CAPTION>

                                             1997                1996
                                           -------            --------
<S>                                        <C>                <C>
Net operating loss carryforward            $  1,072
Capital loss carryforward                       607           $  2,263
Accounts receivable                             283                173
Notes receivable                              1,748                959
Office closing                                                     848
Investments                                   3,927
Inventories                                     298                190
Assets of discontinued operations             2,329                452
Other, net                                      587                398
                                           --------           --------
Gross deferred tax asset                     10,851              5,283
Valuation allowance                            (607)            (2,263)
                                           --------           --------
Deferred tax asset                           10,244              3,020
Fixed assets                                   (666)              (650)
Intangible assets                               (28)              (128)
                                           --------           --------
Deferred tax liability                         (694)              (778)
                                           --------           --------
Net deferred tax asset                     $  9,550           $  2,242
                                           ========           ========
</TABLE>

Discontinued Operations

         The Company recorded gross deferred tax assets of $2,329 and $452 for
discontinued operations for the years ended December 31, 1997 and 1996,
respectively. In connection with the divestitures in 1996, substantially all
net operating loss carryforwards were utilized to reduce income taxes
currently payable. The balance of the valuation allowance at December 31, 1995
was released in 1996 as the utilization of the net operating loss
carryforwards was assured due to the gains recognized on the divestitures. Net
operating loss carryforwards related to discontinued operations amount to
approximately $5.6 million and $0 at December 31, 1997 and 1996 respectively.

<PAGE>   21
Continuing Operations

         The Company recorded gross deferred tax assets of $8,522 and related
valuation allowance of $607 for continuing operations for the year ended
December 31, 1997. The capital loss generated on the sale of Foster Grant
Group and the related valuation allowance were revalued during 1997. Net
operating loss carryforwards related to continuing operations amount to
approximately $2.9 million and $0 at December 31, 1997 and 1996, respectively.
The net operating loss carryforwards begin to expire in the year 2008.

         The Company recorded gross deferred tax assets of $4,831 and related
valuation allowance of $2,263 for continuing operations for the year ended
December 31, 1996. A capital loss carryforward was generated through the sale
of FGG. A valuation allowance of $2,263 was established for the entire net tax
benefit of the capital loss carryforward as the realization was not assured.
The effect on the income tax provision for continuing operations related to
the valuation allowance was a charge of $2,263. The capital loss carryforward
expires in the year 2001.

NOTE 13 - SHARE REPURCHASE PROGRAM

         On September 9, 1996, the Company adopted a share repurchase program
whereby the Company may repurchase, pursuant to Rule 10(b)-18 under the
Securities and Exchange Act of 1934, shares of its common stock in the open
market. The repurchase program became active in December 1996 following
the FGG disposal. Repurchased shares may be issued from time to time upon (i)
exercise of options granted under the Company's 1996 Stock Incentive Plan
and/or (ii) under the Company's 1996 Employee Stock Purchase Plan. During
1996, the Company purchased 58 shares of its common stock at an average price
of $9.60 per share. During 1997, the Company purchased 28 shares of its common
stock at $8.96 per share. During 1997, the Company used 84 treasury shares to
satisfy options exercised. The Company discontinued its share repurchase
program in July 1997, as it was prohibited by the July 1997 amendment to the
Credit Agreement, as amended (See Note 11).

NOTE 14 - STOCK OPTION PLANS

         The Company applies APB Opinion No. 25 and related Interpretations in
accounting for its stock option plans, which are described below. Accordingly,
no compensation cost has been recognized for its stock option plans. Had
compensation cost been determined based on the fair market value at the grant
dates for awards under those plans consistent with the method provided by SFAS
No. 123, the Company's net income (loss) and net income (loss) per share would
have been as set forth in the tables below. All option information has been
restated to give effect to the May 3, 1996 and March 12, 1998 reverse stock
splits.

<TABLE>
<CAPTION>
                                                                YEAR ENDED DECEMBER 31,
                                                          ---------------------------------------
                                                            1997           1996            1995
                                                          --------       --------        --------
<S>                                   <C>                 <C>            <C>           <C>     
Net income (loss)                     As reported         $  (4,933)      $   82,756    $   (6,760)
                                      Pro Forma           $  (6,183)      $   78,592    $  (10,236)
Basic earnings (loss) per share       As reported         $   (0.59)      $     9.69    $    (0.89)
                                      Pro Forma           $   (0.73)      $     9.21    $    (1.34)
Diluted earnings (loss) per share     As Reported         $   (0.59)      $     9.62    $    (0.89)
                                      Pro Forma           $   (0.73)      $     9.14    $    (1.34)
</TABLE>

<PAGE>   22
         The fair value of each option grant is estimated on the date of grant
using the Black-Scholes option pricing model with the following weighted
average assumptions used for all grants:
<TABLE>
<CAPTION>
                                      1997           1996           1995
                                    -------        -------        -------
<S>                                 <C>            <C>            <C>
Dividend yield                          0%             0%             0%
Expected volatility                    50%            64%            64%
Risk free rate of return              6.5%             5%             5%
Expected turnover                       7%             7%             7%
Expected term                        5 years         5 years        5 years
</TABLE>


         The weighted average fair values of Benson options granted during the
years ended December 31, 1996 and 1995 were $10.24 and $9.60, respectively.
The weighted average fair value of the Company options granted during 1997 was
$8.80 and 1996 was $9.26.

         The Company may grant nonqualified stock options, incentive stock
options or stock appreciation rights to officers, directors, consultants and
key employees of the Company.

         Options under the nonqualified stock option plan are granted to
officers, directors and key employees at prices determined by the Company
Board based upon market value on the date of grant. There were no shares
available under the plan for future grants at December 31, 1997. The plan was
amended on March 11, 1998 to increase the number of authorized options and to
ensure current grants were in compliance with the plans.

         As a result of the Essilor Merger and Asset Sale, all Benson options
were canceled. Option holders received consideration (including new Company
options) for their Benson options. Accordingly, all options were issued under
the Company Stock Compensation Plan on or after May 3, 1996.

         A summary of Benson option transactions is as follows:

<TABLE>
<CAPTION>
                                                            OPTION PRICE RANGE       NUMBER OF       EXPIRATION 
                                                                 PER SHARE             OPTIONS           DATE
                                                            ------------------       ---------       ----------
<S>                                                         <C>                      <C>             <C>   
Outstanding at 1/1/95                                          $3.00 - 16.90           1,144         1995 - 2001
Granted                                                       $12.26 - 19.74             284
Exercised                                                      $3.00 - 14.50            (159)
Cancelled                                                     $14.00 - 14.50             (62)
                                                                                     -------
Outstanding at 12/31/95                                        $3.00 - 19.74           1,207         1996 - 2002
Granted                                                       $15.74 - 19.00             134
Exercised                                                      $5.00 - 14.50            (163)
Cancelled                                                      $3.00 - 19.50              (8)
Cancelled in connection with Merger and Asset Sale                                    (1,170)
                                                                                     -------
Outstanding at 12/31/96                                                                  -0-
</TABLE>


<PAGE>   23
         A summary of the Company option transactions is as follows:
<TABLE>
<CAPTION>
                                     WEIGHTED
                              AVERAGE EXERCISE PRICE        NUMBER OF OPTIONS
                              ----------------------        -----------------
<S>                             <C>                         <C>  
Outstanding at 12/31/95                                             -0-
Granted                         $    9.26                         1,025
Exercised                       $    5.42                           (45)
Cancelled                       $    9.88                           (73)
Outstanding at 12/31/96         $    9.40                           907
Exercisable at 12/31/96         $    7.80                           195
                                                                
Granted                         $    8.80                           883
Exercised                       $    8.82                           (83)
Forfeited                       $   10.02                           (57)
Outstanding at 12/31/97         $    9.08                         1,650
Exercisable at 12/31/97         $    8.68                           316
</TABLE>


         Options generally vest evenly over a three-or four-year period
beginning one year from the date of grant and expire seven years from the date
of grant. The 316 exercisable options at 12/31/97 had an option price range of
$1.66 -- $10.25. The weighted average remaining contractual life of the 1,650
options outstanding as of December 31, 1997 was 5.5 years.

         A summary of the price ranges of exercisable and outstanding options 
as of December 31, 1997 and 1996 is as follows:

<TABLE>
<CAPTION>
                                                1997                                         1996
                        -----------------------------------------------------  ----------------------------------------------------
Price Range Per Share      Number of     Weighted Average  Weighted Average       Number of    Weighted Average  Weighted Average
- - ---------------------  -----------     ----------------- -----------------      ---------    ----------------- ----------------
                            Options         Remaining       Exercise Price         options         Remaining       Exercise Price
                            -------         ----------      --------------         -------         ----------      --------------
                                         Contractual Life                                       Contractual Life
                                         ----------------                                       ----------------
<S>                         <C>          <C>                <C>                    <C>          <C>                <C>
Outstanding options:
$ 0.00 - $ 4.00                    6                5.3           $ 2.32                  6               6.3            $ 2.32
$ 4.01 - $ 6.00                   28                5.3           $ 4.88                 28               6.3            $ 4.88
$ 6.01 - $ 8.00                   79                3.2           $ 7.72                 88               4.1            $ 7.72
$ 8.01 - $10.00                  996                6.2           $ 8.80                196               3.8            $ 8.92
$10.01 - $12.00                  541                4.4           $10.10                589               5.1            $10.10
                                 ---                                                    ---
                               1,650                5.5           $ 9.08                907               4.8            $ 9.40
Exercisable options:
$ 0.00 - $ 4.00                    6                              $ 2.32                  6                              $ 2.32
$ 4.01 - $ 6.00                   28                              $ 4.88                 28                              $ 4.88
$ 6.01 - $ 8.00                   69                              $ 7.72                 63                              $ 7.74
$ 8.01 - $10.00                   76                              $ 8.92                 87                              $ 8.86
$10.01 - $12.00                  137                              $10.10                 11                              $10.10
                                 ---                                                     --
                                 316                              $ 8.68                195                              $ 7.80
</TABLE>

<PAGE>   24
NOTE 15 - EARNINGS PER SHARE COMPUTATION

<TABLE>
<CAPTION>
                                           1997                              1996                               1995
                             ------------------------------------------------------------------------------------------------------
                                         Weighted                          Weighted                          Weighted
                                          Average   Per Share               Average   Per Share               Average   Per Share
                                Loss      Shares     Amount     Income     Shares      Amount      Loss      Shares      Amount
                              -------     -------   --------   --------    -------    --------    ------     -------    --------
<S>                             <C>       <C>       <C>        <C>         <C>          <C>        <C>       <C>         <C>
Net income (loss) from
   continuing operations        $(3,651)                        $3,444                             $(949)
Less: Preferred stock
          Dividend                  232
                                -------
BASIC EPS
Income (loss) from
 continuing operations
 available to common
 stockholders                   $(3,883)  8,803     $(0.44)     $3,444      8,537       $0.40      $(949)     7,620     $(0.12)
EFFECT OF DILUTIVE
SECURITIES
Stock options                                                                  63          __
DILUTED EPS
Income from continuing
  operations available to
  common stockholders
  plus assumed conversions      $(3,883)  8,803    $(0.44)      $3,444      8,600       $0.40      $(949)     7,620     $(0.12)
</TABLE>


In 1997 and 1995, due to the net loss from continuing operations, although
there were stock options outstanding, they were not included in the
computation of diluted EPS as the effect would be antidilutive. At December
31, 1997 and 1996 the Company had convertible debt outstanding convertible
into 1,828 shares of common stock. At December 31, 1995 Benson had convertible
debt outstanding convertible into 2,261 shares of common stock. Such shares
were not included in the computation of diluted EPS because the conversion
price was greater than the average market price of the common shares. Warrants
outstanding at December 31, 1997 issued in conjunction with the acquisition of
Bolle France were not included in the calculation of diluted EPS because the
effect would be antidilutive. Such warrants were cancelled on March 11, 1998
in conjunction with Spinoff.

NOTE 16 -- RELATED PARTY TRANSACTIONS

         Ms. Nora Bailey, a member of the Company's Board of Directors since
May 1996, is an attorney specializing in federal tax law. In her professional
capacity she has rendered legal advice and related services to both the
Company and its predecessor, Benson. Ms. Bailey has rendered such services
both prior to and subsequent to her appointment to the Company Board of
Directors, and it is anticipated that from time to time in the future she will
be engaged to provide similar legal services to the Company. All fees paid to
Ms. Bailey in connection with such services have been agreed in arms' length
negotiations and are in accordance with Ms. Bailey's usual and customary
billing practices. Fees paid to Ms. Bailey by the Company in connection with
such services are not paid in consideration of her services as a director.
Aggregate fees billed to Benson and the Company by Ms. Bailey during 1997 and
1996 were approximately $90 and $73, respectively.

<PAGE>   25
         On December 12, 1996, in connection with the sale of FGG by the
Company, Marlin Capital, LP ("Marlin"), a Delaware limited partnership,
invested $2.5 million in convertible preferred stock of the buyer AAi; upon
conversion, AAi common stock received by Marlin would bear demand and
piggyback registration rights. Marlin Holdings, Inc. ("MH"), a Delaware
corporation, is the general partner of Marlin. Mr. Martin E. Franklin, the
Company's Chairman and Chief Executive Officer, is the Chief Executive Officer
and principal stockholder of MH. Mr. Ashken, the Company's Chief Financial
Officer and a Director, also is a stockholder and executive officer of MH. Mr.
Franklin also has been named a member of AAi's Board of Directors.

         Mr. Franklin serves as non-executive chairman of Eyecare Products.
Mr. Ashken serves as a director of Eyecare Products.

NOTE 17 --  COMMITMENTS AND CONTINGENCIES

         The Company is subject to various litigation incidental to business.
Irrespective of any indemnification that may be received, the Company does not
believe that exposure on any matter will result in a significant impact on the
Company's financial condition, results of operations or cash flows.

NOTE 18 -- QUARTERLY FINANCIAL DATA (UNAUDITED)

<TABLE>
<CAPTION>
                    FOR THE YEAR ENDED DECEMBER 31, 1997
                                                                      Q1          Q2         Q3         Q4
- - ----------------------------------------------------------------------------------------------------------------
<S>                                                                 <C>        <C>        <C>         <C>    
Net sales                                                           $10,963    $12,200    $12,058     $12,907
Gross profit                                                          4,457      4,520      4,459       4,089
Income (loss) from continuing operations                              1,038        993        699      (6,381)
Basic and diluted earnings (loss) per share                         $  0.12    $  0.11    $  0.07     $ (0.74)
from continuing operations
</TABLE>
<TABLE>
<CAPTION>

  FOR THE YEAR ENDED DECEMBER 31, 1996
                                                                      Q1          Q2         Q3         Q4
- - ----------------------------------------------------------------------------------------------------------------
<S>                                                                 <C>        <C>        <C>         <C>    
Net sales                                                           $10,771    $11,206    $10,007     $10,590
Gross profit                                                          4,281      4,328      4,025       4,264
Income from continuing operations                                       779      1,210      1,045         410
Basic and diluted earnings per share from continuing                $  0.09    $  0.14    $  0.12     $  0.05
operations
</TABLE>

<TABLE>
<CAPTION>
  FOR THE YEAR ENDED DECEMBER 31, 1995
                                                                      Q1          Q2         Q3         Q4
- - ----------------------------------------------------------------------------------------------------------------
<S>                                                                 <C>        <C>        <C>         <C>    
Net sales                                                            $9,547    $10,511     $9,875     $11,311
Gross profit                                                          4,324      4,745      3,728       4,722
Income (loss) from continuing operations                                145        629     (1,083)       (640)
Basic and diluted earnings (loss) per share from continuing          $ 0.02    $  0.09     $(0.14)    $ (0.09)
operations
</TABLE>


<PAGE>   1
                                                                    Exhibit 99.2
                   ILC TECHNOLOGY, INC. FINANCIAL STATEMENTS


                              ILC TECHNOLOGY, INC.
                           CONSOLIDATED BALANCE SHEETS
                    SEPTEMBER 27, 1997 AND SEPTEMBER 28, 1996

                                     ASSETS

<TABLE>
<CAPTION>
                                                       1997              1996 
                                                       ----              ---- 
<S>                                                   <C>            <C>       
Current assets:                                                                
                                                                               
 Cash and cash equivalents .......................    $ 1,113,992    $ 1,828,807

 Accounts receivable, less allowance for
  doubtful accounts of $337,958 and $312,358,
  respectively ...................................      9,485,397      9,494,246

 Receivable from long-term contracts .............      1,049,122        861,427

 Inventories, net ................................     10,716,680      8,901,528

 Deferred tax asset ..............................        835,803      2,158,000

 Prepaid expenses ................................        344,393        208,320

 Current portion of note receivable from
  sale of PLI ....................................      1,150,000             -- 

 Net assets from discontinued operations .........             --      2,178,383
                                                      -----------    -----------

    Total current assets .........................     24,695,387     25,630,711
                                                      -----------    -----------



 Property and equipment, net .....................     21,652,695     21,176,431

 Note receivable from sale of PLI, net
  of current portion .............................      2,196,871             -- 

 Covenants-not-to-compete, net of
  accumulated amortization and writedown of
  $3,314,404 and $3,195,524, respectively ........        237,761        356,641

 Other assets ....................................        765,309        680,013
                                                      -----------    -----------

                                                      $49,548,023    $47,843,796
                                                      ===========    ===========
</TABLE>

  The accompanying notes are an integral part of these financial statements.

<PAGE>   2

                              ILC TECHNOLOGY, INC.
                          CONSOLIDATED BALANCE SHEETS
                   SEPTEMBER 27, 1997 AND SEPTEMBER 28, 1996



                      LIABILITIES AND STOCKHOLDERS' EQUITY






<TABLE>
<CAPTION>
                                                         1997            1996 
                                                     -----------     -----------
<S>                                                  <C>             <C>        
Current liabilities:

   Accounts payable ............................     $ 4,361,816     $ 3,643,496
   Accrued payroll and related
    items ......................................       1,701,209       1,263,741
   Other accrued liabilities ...................       1,517,606       1,146,822
   Current portion of non-compete
    obligation .................................              --         390,000
   Current portion of long-term
    debt .......................................       2,534,500       2,545,600
   Accrued income taxes payable ................       1,243,451       1,486,518
                                                     -----------     -----------

         Total current liabilities .............      11,358,582      10,476,177
                                                     -----------     -----------

Long-term liabilities, net of
 current portion:

   Long-term debt ..............................       3,117,396       7,370,164
   Other accruals ..............................          78,328         206,235
                                                     -----------     -----------

          Total long-term liabilities ..........       3,195,724       7,576,399
                                                     -----------     -----------

Commitments and contingencies (Note 8)

Stockholders' equity:

   Common stock, no par value;
    10,000,000 shares authorized;
    4,874,040 shares and 4,782,508
    shares outstanding, respectively ...........       7,178,231       6,815,109

   Retained earnings ...........................       7,815,486      22,976,111
                                                     -----------     -----------

         Total stockholders' equity ............      34,993,717      29,791,220
                                                     -----------     -----------

                                                     $49,548,023     $47,843,796
                                                     ===========     ===========
</TABLE>

  The accompanying notes are an integral part of these financial statements.
<PAGE>   3
                              ILC TECHNOLOGY, INC.
                     CONSOLIDATED STATEMENTS OF OPERATIONS
              FOR THE THREE FISCAL YEARS ENDED SEPTEMBER 27, 1997

<TABLE>
<CAPTION>
                                                    1997           1996            1995
                                               ------------   ------------    ------------

<S>                                            <C>            <C>             <C>         
Net sales ..................................   $ 55,517,905   $ 54,206,424    $ 49,496,029

Costs and expenses:
  Cost of sales ............................     39,194,377     36,180,448      31,799,916
  Research and development .................      4,252,694      4,319,650       4,278,697
  Sales and marketing ......................      3,059,158      2,645,952       2,404,856
  General and administrative ...............      4,329,067      4,417,446       4,459,726
  Amortization of intangibles ..............        120,000        120,000         120,000
                                               ------------   ------------    ------------
                                                 50,955,296     47,683,496      43,063,195

Income from continuing
 operations before provision for
 income taxes, interest expense
 and gain on sale of CPI ...................      4,562,609      6,522,928       6,432,834


Interest expense, net ......................        493,917        461,898         323,757
                                               ------------   ------------    ------------

Income from continuing
 operations before provision for
 income taxes and before gain
 on sale of CPI ............................      4,068,692      6,061,030       6,109,077

Gain on sale of CPI ........................      2,378,683             --              --
                                               ------------   ------------    ------------

Income from continuing
 operations before provision for
 income taxes ..............................      6,447,375      6,061,030       6,109,077

Provision for income taxes on
 continuing operations .....................      1,608,000      1,515,000       1,472,000
                                               ------------   ------------    ------------

Income from continuing operations...........      4,839,375      4,546,030       4,637,077

Discontinued operations:
  Operating loss, net of tax
  benefit of $280,000 and
  $32,000 in 1996 and
   1995, respectively ......................             --       (840,217)        (99,143)

  Estimated loss on disposal,
   including $500,000 for operating
   losses during the phase out,
   net of tax benefit of
   $1,132,996 ..............................             --     (3,398,987)             --
                                               ------------   ------------    ------------

  Loss from discontinued operations ........             --     (4,239,204)        (99,143)
                                               ------------   ------------    ------------

Net income .................................   $  4,839,375   $    306,826    $  4,537,934
                                               ============   ============    ============
Earnings (loss) per share:
 Earnings from continuing
  operations ...............................   $       0.96           0.92    $       0.97
 Loss from discontinued operations .........             --          (0.86)          (0.02)
                                               ------------   ------------    ------------

Net income per share .......................   $       0.96   $       0.06    $       0.95
                                               ============   ============    ============

Weighted average shares
 outstanding used to compute
 net income (loss) per share ...............      5,047,658      4,923,132       4,764,989
                                               ============   ============    ============
</TABLE>

 The accompanying notes are an integral part of these financial statements.

<PAGE>   4



                              ILC TECHNOLOGY, INC.
                           CONSOLIDATED STATEMENTS OF
                              STOCKHOLDERS' EQUITY
              FOR THE THREE FISCAL YEARS ENDED SEPTEMBER 27, 1997






<TABLE>
<CAPTION>
                                                    Common
                                      Common         Stock        Retained
                                      Shares         Amount        Earnings        Total
                                    ---------    ------------    ------------   ------------
<S>                                 <C>          <C>             <C>            <C>         
Balance at October 1, 1994 .....    4,522,951    $  5,492,338    $ 18,131,351   $ 23,623,689

  Net income ...................           --              --       4,537,934      4,537,934

  Issuance of common
   stock under stock
   purchase plan ...............       37,973         266,575              --        266,575

  Exercise of stock options ....      132,250         450,751              --        450,751

  Repurchase of common stock ...      (10,000)        (76,750)             --        (76,750)


Balance at September 30,
 1995 ..........................    4,683,174       6,132,914      22,669,285     28,802,199

  Net income ...................           --              --         306,826        306,826

  Issuance of common
   stock under stock
   purchase plan ...............       34,209         279,068              --        279,068

  Exercise of stock options ....       65,125         403,127              --        403,127
                                 ------------    ------------    ------------   ------------


Balance at September 28,
 1996 ..........................    4,782,508       6,815,109      22,976,111     29,791,220

  Net income ...................           --              --       4,839,375      4,839,375

  Issuance of common
   stock under stock
   purchase plan ...............       28,555         266,588              --        266,588

  Exercise of stock options ....       99,977         521,992              --        521,992

  Repurchase of common stock ...      (37,000)       (425,458)             --       (425,458)
                                 ------------    ------------    ------------   ------------


Balance at September 27,
 1997 ..........................    4,874,040    $  7,178,231    $ 27,815,486   $ 34,993,717
                                 ============    ============    ============   ============
</TABLE>


 The accompanying notes are an integral part of these financial statements.
<PAGE>   5
                              ILC TECHNOLOGY, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
              FOR THE THREE FISCAL YEARS ENDED SEPTEMBER 27, 1997

<TABLE>
<CAPTION>
                                               1997           1996           1995
                                           -----------    -----------    -----------
<S>                                        <C>            <C>            <C>        
Cash flows from operating
 activities:
  Net Income ............................  $ 4,839,375    $   306,826    $ 4,537,934

  Adjustment to reconcile net
   income to net cash provided by
   continuing operations:

  Discontinued operations ...............           --      4,239,204         99,143

  Depreciation and amortization .........    2,002,845      1,689,689      1,569,478

  Provision for doubtful accounts .......       68,694         38,804        102,861

  Provision for inventory obsolescence ..      696,089        520,006        169,034

  Net loss on property and equipment
   sold or retired ......................       14,144             --         26,367

  Equity in income of joint venture .....     (106,000)       (20,000)       (89,000)

  Gain on sale of CPI ...................   (2,378,683)            --             --

  Changes in assets and liabilities,
   net of effects of businesses sold:

  Decrease in marketable securities .....           --             --        998,129

  Increase in accounts receivable .......   (1,494,632)    (1,333,378)    (2,467,329)

  Increase in inventories ...............   (4,267,013)    (1,888,444)    (1,685,743)

  (Increase) decrease in deferred
   tax asset ............................    1,322,197       (704,000)       951,000

  (Increase) decrease in prepaid
   expenses .............................     (136,073)       (86,076)       406,556

  (Increase) decrease in other
    assets ..............................       20,704         79,823         (9,397)

  Increase (decrease) in accounts
   payable ..............................      718,320       (120,502)       300,709

  Decrease in accrued liabilities .......     (230,124)      (956,660)      (637,731)
                                           -----------    -----------    -----------
    Net cash provided by operating
     activities from continuing
     operations .........................    1,069,843      1,765,292      4,272,011

    Net cash used in discontinued
     operations .........................   (1,518,488)      (168,186)    (1,722,659)
                                           -----------    -----------    -----------

  Cash flows from investing activities:

  Proceeds from sale of CPI .............    6,350,000             --             --

  Payments received on note for
   sale of PLI ..........................      350,000             --             --

  Purchase of land and real estate ......           --             --     (3,045,412)

  Decrease in deposit on land and
   building purchase ....................           --             --      1,300,000

  Investment in joint venture ...........           --             --       (450,000)

  Capital expenditures ..................   (3,102,092)    (3,186,557)    (2,517,541)
                                           -----------    -----------    -----------
    Net cash provided by (used in)
     investing activities ...............    3,597,908     (3,186,557)    (4,712,953)
                                           -----------    -----------    -----------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

<PAGE>   6



                              ILC TECHNOLOGY, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
               FOR THE THREE FISCAL YEARS ENDED SEPTEMBER 27, 1997

                                   (continued)


<TABLE>
<CAPTION>
                                              1997             1996           1995
                                              ----             ----           ----
<S>                                       <C>              <C>             <C>       
Cash flows from financing activities:
  Principal borrowings under line of
    credit.............................   $ 10,963,000     $ 9,500,000     $ 8,450,000
  Principal repayments under line of
    credit.............................    (13,463,000)     (6,500,000)     (6,450,000
  New borrowings under equipment line..      1,045,000       1,555,000       1,720,059
  Principal repayments under 
    equipment line.....................     (1,321,200)     (1,374,800)     (1,049,958)
  Principal repayments under term
    loan...............................     (1,451,000)     (1,584,000)     (1,578,000)
  Payments under non-compete
    agreement..........................             --        (390,000)       (520,000)
  Proceeds from issuance of common
    stock..............................        788,580         682,195         717,326
  Repurchase of common stock...........       (425,458)             --         (76,750)
                                          ------------     -----------     -----------
      Net cash provided by (used in)
        financing activities...........     (3,864,078)      1,888,395       1,212,707
                                          ------------     -----------     -----------
      Net increase (decrease) in
        cash and cash equivalents......       (714,815)        198,944        (950,894)

Cash and cash equivalents at
  beginning of year....................      1,828,807       1,529,863       2,480,757
                                          ------------     -----------     -----------
Cash and cash equivalents at end
  of year..............................   $  1,113,992     $ 1,828,807     $ 1,529,863
                                          ============     ===========     ===========
</TABLE>


<TABLE>
<CAPTION>
                                              1997         1996        1995
                                              ----         ----        ----
<S>                                       <C>            <C>       <C>       
Supplemental disclosures of cash
 flow information:

Cash paid during the year for:
 Interest - continuing operations......   $  641,127   $  542,061  $  589,200
 Interest - discontinued operations....           --       77,714     106,341
 Income taxes..........................      282,898    1,055,000     909,000
</TABLE>


Supplemental disclosure of non-cash activities:

ILC sold the  stock of PLI for a note.  The  purchase  price,  net of  expenses,
approximated the net assets of PLI (Note 12).

  The  accompanying  notes are an integral part of these financial statements.
<PAGE>   7



                              ILC TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 27, 1997



1. The Company

         ILC Technology, Inc. ("ILC") was incorporated on September 15, 1967.
ILC designs, develops, manufactures and markets high intensity lamps and
lighting products for the medical, industrial, aerospace, scientific,
entertainment and military industries. ILC develops and manufactures the
majority of its products at its headquarter facilities in California and the
remainder at its subsidiary facility in the United Kingdom. (See Notes 12, 13
and 16).

2.  Summary of Significant Accounting Policies

Basis of Presentation

         The consolidated financial statements include the accounts of ILC and
its wholly owned subsidiaries. All significant intercompany balances and
transactions have been eliminated.

         Fiscal year 1995 was restated to reflect ILC's decision to discontinue
the operations of Precision Lamp, Inc. ("PLI") (see Note 12). This restatement
had no impact on net income.

         ILC's fiscal year end is the Saturday closest to September 30.

Use of Estimates in Preparation of Financial Statements

         The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates. Items which
require management to make estimates include the realization of accounts
receivable and inventory balances, warranty, and other reserves. Additionally,
ILC is currently in negotiation with PLI Acquisition Corp. to restructure the
terms of that note receivable, as discussed in Note 12.

Cash and Cash Equivalents

         For the purpose of the statement of cash flows, ILC considers all
highly liquid investments with an original maturity of three months or less at
the time of issue to be cash equivalents.


Inventories

         Inventories are stated at the lower of cost (first-in, first-out) or
market, and include material, labor and manufacturing overhead. Inventories at
September 27, 1997 and September 28, 1996, net of inventory reserves of
$2,043,420 and $2,034,258, respectively, consisted of:
<PAGE>   8

2.  Summary of Significant Accounting Policies (continued)

Inventories (continued)


<TABLE>
<CAPTION>
                                   1997                       1996
                                   ----                       ----
<S>                            <C>                         <C>        
Raw materials                   $5,459,159                 $ 4,802,839
Work-in-process                  3,974,496                   2,549,805
Finished goods                   1,283,025                   1,548,884
                                ----------                 -----------
Total inventories              $10,716,680                 $ 8,901,528
                               ===========                 ===========
</TABLE>



Developmental and Manufacturing Contracts

         ILC contracts with the U.S. Government and other customers for the
development and manufacturing of various products under both cost-plus-fixed-fee
and fixed-price contracts. Revenues are recognized under these contracts using
the percentage of completion method, whereby revenues are reported in the
proportion that costs incurred bear to the total estimated costs for each
contract. Periodic reviews of estimated total costs during the performance of
such contracts may result in revisions of contract estimates in subsequent
periods. Any loss contracts are reserved at the time such losses are determined.
Revenues from these contracts were less than 10% of net revenues during 1997,
1996 and 1995.


Depreciation and Amortization

         Depreciation and amortization on property and equipment are provided on
a straight-line basis over estimated useful lives of 3 to 31.5 years, except for
leasehold improvements which are amortized over the terms of the leases.


Net Income (Loss) Per Share

      Net income (loss) per share is computed using the weighted  average number
of common  shares and common  equivalent  shares (when such  equivalents  have a
dilutive effect)  outstanding during the period using the treasury stock method.
Fully diluted net income (loss) per share is not  significantly  different  from
net income (loss) per share as reported.


      In February 1997, the Financial Accounting Standards Board issued SFAS No.
128, which requires  disclosure of basic earnings per share and diluted earnings
per share and is effective  for periods  ending  subsequent to December 15, 1997
and restatement  will be required for all prior period EPS data  presented.  The
pro forma effect of adoption of SFAS No. 128 is included in the table below.
<PAGE>   9

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Net Income (Loss) Per Share (continued)


<TABLE>
<CAPTION>
                                          1997        1996         1995
                                       ---------   ---------    ---------
                                               (shares in thousands)
<S>                                   <C>         <C>          <C>  
As reported:
  Earnings (loss) per share:
  Continuing operations ............   $    0.96   $    0.92    $    0.97
  Discontinued operations ..........          --       (0.86)       (0.02)
                                       ---------   ---------    ---------
   Net income per share ............   $    0.96   $    0.06    $    0.95

Pro forma for SFAS No. 128:
  Basic earnings (loss) per share:
  Continuing operations ............   $    1.00   $    0.96    $    1.01
  Discontinued operations ..........          --       (0.90)       (0.02)
                                       ---------   ---------    ---------
  Basic net income per share .......   $    1.00   $    0.06    $    0.99
  Weighted average number of
   common shares outstanding .......       4,848       4,725        4,604

  Diluted earnings (loss) per share:
  Continuing operations ............   $    0.96   $    0.92    $    0.97
  Discontinued operations ..........          --       (0.86)       (0.02)
                                       ---------   ---------    ---------
  Diluted net income per share .....   $    0.96   $    0.06    $    0.95
  Weighted average number of
   common shares outstanding .......       5,048       4,923        4,765
</TABLE>




Covenants-Not-To-Compete

         The covenant-not-to-compete relates to the Q-Arc acquisition that took
place in 1991. This is being amortized over the period of the covenant.

         In March 1995, the Financial Accounting Standards Board issued
Statement of Financial Accounting Standards No. 121, "Accounting for the
Impairment of Long-Lived Assets and for Long- Lived Assets to be Disposed Of."
ILC adopted the provisions of this statement in fiscal 1996. The effect on its
financial position and results of operations was not significant. ILC quarterly
evaluates whether later events and circumstances have occurred that indicate the
remaining estimated useful lives of these intangibles may warrant revision or
that the remaining balances of intangibles may not be recoverable. When factors
indicate that intangibles should be evaluated for possible impairment, ILC uses
an estimate of the related subsidiary's undiscounted cash flow over the
remaining life of the intangibles in measuring whether the intangibles are
recoverable. As part of ILC's decision to discontinue the operations of PLI, the
unamortized balance of the covenant-not-to-compete ($470,000) was written off in
the fourth quarter of fiscal 1996.


Investment in Joint Venture

         In February 1995, ILC invested $450,000 in a lamp manufacturer located
in Japan. ILC's investment represents a 49% ownership interest in the equity of
the investee, consequently ILC accounts for its investment using the equity
method of accounting. ILC's investment is included in Other Assets in the
accompanying consolidated balance sheets and its proportionate interest in the
income of the

<PAGE>   10

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Investment in Joint Venture (continued)

investee of $106,000, $20,000 and $89,000 in fiscal 1997, 1996 and 1995,
respectively, is included in the accompanying consolidated statements of
operations.


New Accounting Pronouncements

         SFAS No. 130, "Reporting Comprehensive Income", establishes guidelines
for all items that are to be recognized under accounting standards as components
of comprehensive income to be reported in the financial statements. The
statement is effective for all periods ending after December 15, 1997 and
reclassification of financial statements for earlier periods presented will be
required for comparative purposes.

         SFAS No. 131, "Disclosures about Segments of an Enterprise and Related
Information", establishes standards for reporting of operating segment
information in annual financial statements and requires that those enterprises
report selected information about operating segments in interim financial
statements issued to shareholders. The statement is effective for all periods
ending after December 15, 1997.


3.  Revenues

         ILC recognizes revenue on all product sales upon shipment of the
product. ILC accrues for estimated warranty obligations at the time of the sale
of the related product based upon its past history of claims experience and
costs to discharge its obligations.

         ILC operates in a single industry segment, the designing, developing,
manufacturing and marketing of high performance light source products. Revenues
from continuing operations are geographically summarized as follows (in
thousands):

<TABLE>
<CAPTION>
                        1997      1996      1995
                      -------   -------   -------
<S>                   <C>       <C>       <C>    
United States .....   $36,639   $34,088   $32,533
Europe ............     6,671     6,920     5,964
Asia ..............    11,986    12,700    10,951
Other international       222       498        48
                      -------   -------   -------
                      $55,518   $54,206   $49,496
                      =======   =======   =======
</TABLE>



Customers comprising more than 10% of net sales from continuing operations are
as follows:

<TABLE>
<CAPTION>
                                      1997          1996           1995    
                                      ----          ----           ----    
                                                                           
<S>                                   <C>           <C>            <C>     
Customer A.........................   13.5%         15.0%          12.2%   
Customer B.........................     *           11.5%          12.0%   
</TABLE>

*less than 10% of net sales
<PAGE>   11

3.  Revenues (continued)

         ILC provides credit in the form of trade accounts receivable to its
customers. ILC does not generally require collateral to support customer
receivables. ILC performs ongoing credit evaluations of its customers and
maintains allowances which management believes are adequate for potential credit
losses.

         Approximately 31%, 39% and 40% of ILC's sales in fiscal 1997, 1996 and
1995, respectively, were to customers in the medical industry. This industry has
experienced significant fluctuations in demand and ILC expects sales to the
medical market to decrease as a percentage of net sales in the foreseeable
future. Customer B, referred to above, is in the semiconductor equipment
industry and was a major customer of ILC's subsidiary, CPI. In the fourth
quarter of fiscal 1996, CPI experienced a significant reduction in orders from
this customer. In May 1997, CPI was sold (see Note 13).

4.  Property and Equipment

         Property and equipment at September 27, 1997 and September 28, 1996
consisted of:

<TABLE>
<CAPTION>
                                         1997            1996
                                    ------------    ------------
<S>                                 <C>             <C>         
Property and equipment, at cost:
   Machinery and equipment ......   $ 17,130,338    $ 15,047,138
   Land and buildings ...........     15,498,058      14,955,738
   Furniture and fixtures .......        518,283         601,822
   Equipment under capital lease         174,268         174,268
   Leasehold improvements .......             --         598,814
   Construction-in-progress .....        577,449       1,011,601
                                    ------------    ------------
                                      33,898,396      32,389,891
Less accumulated depreciation and
   amortization .................    (12,245,701)    (11,212,950)
                                    ------------    ------------

Property and equipment, net .....   $ 21,652,695    $ 21,176,431
                                    ============    ============
</TABLE>


5.  Bank Borrowings

         As of September 27, 1997 and September 28, 1996, borrowings outstanding
under ILC's credit facilities consisted of:

<TABLE>
<CAPTION>
                                1997           1996
                           -----------    -----------
<S>                        <C>            <C>        
Line of credit .........   $ 2,500,000    $ 5,000,000
Term loan ..............     1,187,000      2,638,000
Equipment line of credit     1,915,000      2,191,200
Other capital lease ....        49,896         86,564
                           -----------    -----------
                             5,651,896      9,915,764

Less: current portion ..    (2,534,500)    (2,545,600)
                           -----------    -----------

Long-term debt .........   $ 3,117,396    $ 7,370,164
                           ===========    ===========
</TABLE>





         Aggregate maturities for long-term debt during the next five years are
approximately: 1998 - $2,534,500, 1999 - $3,117,396, and none in 2000, 2001 and
2002.
<PAGE>   12



5.  Bank Borrowings (continued)

         All of the above credit facilities are secured by all of the property
of ILC.

         ILC has a $6 million line of credit available with a bank which expires
in March 1999. Borrowings under this line are at 2% above the LIBOR rate (London
Interbank Offer Rate) (7.66% at September 27, 1997). Under the covenants of the
loan agreement, unless written approval from the bank is obtained, ILC is
restricted from entering into certain transactions and is required to maintain
certain specified financial covenants and profitability. As of September 27,
1997, ILC was in compliance with all financial covenants. The average balance
outstanding (based on month-end balances) under the line of credit in 1997 was
$4,021,000. The maximum borrowings were $6,000,000 and the average interest rate
during 1997 was 7.6%. As of September 27, 1997, $3.5 million was available for
future borrowings under this line of credit.

         In addition, in connection with the purchase of its Sunnyvale
manufacturing facilities, ILC entered into a term loan with a bank for
$5,000,000 in 1993, which was subsequently increased to $6,333,333 in 1994. The
note matures in August 1998. The term loan requires monthly principal payments
equal to one-forty-eighth of the principal amount plus interest at 2% above the
LIBOR rate (London Interbank Offer Rate) (7.66% at September 27, 1997). The term
loan is a reducing revolving credit facility which allows for principal
pre-payments and the flexibility for re-borrowing up to the maximum amount that
would be outstanding under the term loan given normal amortization to the date
of re-borrowing. The average balance outstanding (based on month-end balances)
under the term loan in 1997 was $1,913,000, and the average interest rate during
1997 was 7.6%.

         ILC has available equipment lines of credit for 100% of the purchase
cost of new equipment. At the end of fiscal 1997, ILC had borrowings under these
lines of $1,915,000, of which $1,348,000 is due in fiscal 1998 and $567,000 is
due in fiscal 1999. These borrowings bear interest at 2% above the LIBOR rate
(7.66% at September 27, 1997). ILC also has available an unused $2 million
equipment line of credit which expires in August 1998. Borrowings under this
line bear interest at the same rate as discussed above, with principal balances
amortized over a 2 year period.


6.  Income Taxes

         ILC accounts for income taxes under SFAS No. 109, "Accounting for
Income Taxes." SFAS No. 109 requires an asset and liability approach to
accounting for income taxes.

         Income from continuing operations before provision for income taxes
consists of the following for fiscal 1997, 1996 and 1995, respectively:



<TABLE>
<CAPTION>
                                         1997         1996          1995
                                     ----------    ----------    ----------
<S>                                  <C>          <C>            <C>       
U.S................................  $4,738,375   $4,897,389     $5,588,040
Foreign............................   1,709,000    1,163,641        521,037
                                     ----------    ----------    ----------
                                     $6,447,375    $6,061,030    $6,109,077
                                     ==========    ==========    ==========
</TABLE>



         The components of the provision for income taxes on continuing
operations are as follows:
<PAGE>   13



6.  Income Taxes (continued)

<TABLE>
<CAPTION>
                                        1997          1996           1995
                                   -----------   -----------    -----------
<S>                                <C>           <C>            <C>        
Federal -
      Current ..................   $   671,000   $ 1,559,000    $   833,000
      Deferred .................        80,000      (600,000)       581,500
                                   -----------   -----------    -----------
                                       751,000       959,000      1,414,500
                                   -----------   -----------    -----------
Foreign -
      Current ..................       540,000       384,000             --

State -
      Current ..................       241,000       276,000        199,000
      Deferred .................        76,000      (104,000)        96,500
                                   -----------   -----------    -----------
                                       317,000       172,000        295,500
                                   -----------   -----------    -----------

Federal refund received ........            --            --       (238,000)
                                   -----------   -----------    -----------

Total provision for income taxes
 on continuing operations ......   $ 1,608,000   $ 1,515,000    $ 1,472,000
                                   ===========   ===========    ===========
</TABLE>



         The major components of the deferred tax asset account, as computed
under SFAS No. 109, are as follows:


<TABLE>
<CAPTION>
                                         1997           1996
                                    -----------    -----------
<S>                                 <C>            <C>        
Reserve for loss on disposal of
 discontinued operations, not
 currently deductible for tax
 purposes .......................   $        --    $ 1,133,000
Inventory reserve ...............       795,000        877,000
Bad debt reserve ................       132,000         92,000
Warranty reserve ................       103,000        128,000
Accruals not currently deductible
 for tax purposes ...............       545,000        381,000
Amortization of covenant-not-
 to-compete .....................            --        202,000
Excess of tax over book
 depreciation ...................    (1,112,000)      (988,000)
Other items, individually
 insignificant ..................       372,803        333,000
                                    -----------    -----------
                                    $   835,803    $ 2,158,000
                                    ===========    ===========
</TABLE>



         The provision for income taxes on continuing operations differs from
the amounts which would result by applying the applicable statutory Federal
income tax rate to income from continuing operations before taxes as follows:

<TABLE>
<CAPTION>
                                   1997           1996           1995
                              -----------    -----------    -----------
<S>                           <C>            <C>            <C>        
Computed expected provision   $ 2,192,000    $ 2,121,000    $ 2,138,000
State tax .................       317,000        364,000        367,000
FSC commission ............       (43,000)      (181,000)      (216,000)
General business credits ..      (277,000)      (218,000)      (203,000)
Refund received ...........            --             --       (238,000)
Other items, individually
 insignificant ............      (581,000)      (571,000)      (376,000)
                              -----------    -----------    -----------
                              $ 1,608,000    $ 1,515,000    $ 1,472,000
                              ===========    ===========    ===========
</TABLE>

<PAGE>   14



6.  Income Taxes (continued)

         During the second quarter of fiscal 1995, ILC received a refund of
$238,000 from the Internal Revenue Service (IRS) related to tax returns filed in
previous years, which were examined by the IRS. This amount was recorded as a
reduction of the fiscal 1995 tax provision upon receipt of the refund. An
additional $235,000 of interest related to the refund amount was received and
was included in interest income in fiscal 1995.


7.  Employee Retirement Plan

         On January 1, 1984, ILC adopted a thrift incentive savings plan (the
"Retirement Plan"). The Retirement Plan is qualified under section 401(k) of the
Internal Revenue Code and is available to all full-time employees with one or
more years of employment with ILC. Under the terms of the Retirement Plan,
participating employees must contribute at least 2% of their salary to the
Retirement Plan, and ILC contributes (as a matching contribution) 100% of this
amount. Employees may also contribute an additional amount up to 13% of their
salary to the Retirement Plan, with no further contributions by ILC. ILC's
contributions vest at a rate of 20% per year, commencing on the first
anniversary of employment. Total employer matching contributions under the
Retirement Plan were $187,000, $226,000, and $212,000 for fiscal years 1997,
1996 and 1995, respectively. The components of such expense relating to
continuing operations was $187,000, $188,000 and $171,000 for fiscal years 1997,
1996 and 1995, respectively.


8.  Commitments and Contingencies

         At September 27, 1997, all of ILC's facilities in Sunnyvale and Santa
Clara, California and Cambridge, England are owned. All lease obligations
associated with the facilities of PLI and CPI were assumed by the buyers at the
time of sale.

         For fiscal years 1997, 1996 and 1995, rental expense was approximately
$178,000, $442,000 and $277,000, respectively. Rental expense for continuing
operations was $121,000, $226,000 and $61,000 for fiscal years 1997, 1996 and
1995, respectively.

         As discussed in Note 13, the number of shares held in escrow relating
to the sale of CPI are subject to adjustment related to warranties and the
valuation of the acquiror's common stock.

9.  Stock Option and Purchase Plans

         Under the 1992 Stock Option Plan ("Plan"), ILC may grant options to
employees and directors. ILC has reserved 575,000 shares for issuance under the
Plan. The exercise price per share for stock options cannot be less than the
fair market value on the date of grant. Options granted are for a ten-year term
and generally vest ratably over a period of four years commencing one year after
the date of grant. The Plan provides for the automatic grant of a nonstatutory
stock option to purchase shares of Common Stock to each outside Director
annually during ILC's third fiscal quarter. During fiscal 1997, each outside
Director was granted an automatic option to purchase a total of 5,000 shares of
ILC's Common Stock. ILC's 1983 Stock Option Plan expired in 1993 and no further
options have been granted under such plan since then.

         In accordance with the disclosure requirements of Statement of
Financial Accounting Standards No. 123 " Accounting for Stock-Based
Compensation," if ILC had elected to recognize compensation cost based on fair
value of the options granted at grant dates prescribed, income from continuing
operations and
<PAGE>   15



9.  Stock Option and Purchase Plans (continued)

earnings per share would have been reduced to the pro forma amounts indicated in
the table below. The pro forma effect on net income for fiscal 1997 and 1996 is
not representative of the pro forma effect on net income in future years because
it does not take into consideration pro forma compensation expense related to
grants made prior to fiscal 1996.

<TABLE>
<CAPTION>
                                          1997            1996
                                     -------------   -------------
<S>                                  <C>             <C>          
Income from continuing operations-
 as reported .....................   $   4,839,375   $   4,546,030
Income from continuing operations-
 pro forma .......................   $   4,328,487   $   4,344,547


Earnings per share from continuing
 operations as reported ..........   $        0.96   $        0.92
Earnings per share from continuing
 operations-pro forma ............   $        0.89   $        0.89
</TABLE>




         The fair value of each option grant is estimated on the date of grant
using the Black-Scholes option pricing model utilizing expected volatility
calculations based on historical data (62.10%) and risk-free interest rates
based on U.S. government bonds on the date of grant with maturities equal to the
expected option term (5.82%-6.69%). No dividends are assumed, and the expected
option term is 5.93 years. The weighted-average fair values of options granted
in fiscal 1997 and 1996 are $6.49 and $6.27, respectively.
<PAGE>   16



9.  Stock Option and Purchase Plans (continued)

         A summary of ILC's stock option activity for the past three fiscal
years is as follows:


<TABLE>
<CAPTION>
                                                                              Weighted
                                   Options                  Exercise          Average
                                  Available    Number         Price           Exercise
                                  for Grant   of Shares      Per Share         Price
                                  --------    --------    --------------   --------------
                                                       Options Outstanding
                                              -------------------------------------------
<S>                               <C>         <C>         <C>              <C>           
Balance at October 1, 1994 ....... 103,624     720,027       $1.09-11.50   $         6.27

 Granted ......................... (28,000)     28,000       $      9.50   $         9.50
 Canceled ........................  34,000     (34,000)      $8.75-11.50   $         9.85
 Exercised .......................      --    (132,250)       $2.13-8.75   $         3.48
                                  --------    --------    --------------   --------------

Balance at September 30, 1995 .... 109,624     581,777       $1.09-11.50   $         6.87

 Additional shares approved ...... 200,000          --                --               --
 Granted .........................(205,000)    205,000       $9.00-11.25   $         9.94
 Canceled ........................  92,125     (92,125)      $8.75-11.50   $        10.27
 Exercised .......................      --     (65,125)      $1.09-11.50   $         6.10
                                  --------    --------    --------------   --------------

Balance at September 28, 1996 .... 196,749     629,527      $1.09 -11.50   $         7.44

 Additional shares approved ...... 175,000          --                --               --
 Granted .........................(406,000)    406,000       $9.00-11.19   $        10.29
 Canceled ........................  89,550     (89,550)      $9.00-11.50   $        10.57
 Exercised .......................      --     (99,977)      $1.09-11.50   $         5.22
                                  --------    --------    --------------   --------------

Balance at September 27, 1997 ....  55,299     846,000       $2.25-11.25   $         8.74
                                  ========    ========    ==============   ==============
</TABLE>




         At the end of fiscal 1997, 1996 and 1995, options to purchase 351,063
shares, 416,965 shares and 439,715 shares, respectively, were exercisable at
weighted average prices of $6.70, $6.11 and $5.94.

         The following table summarizes information about stock options
outstanding at September 27, 1997:


<TABLE>
<CAPTION>
                                           Weighted Avg.                 Weighted Avg.
Number of     Exercise     Weighted Avg.   Remaining       Number of     Exercise Price
Shares        Price        Exercise        Contractual     Shares        of Options
Outstanding   Range        Price           Life            Exercisable   Exercisable
- -----------   -----------  -------------  -----------      -----------   -------------

<S>           <C>          <C>             <C>              <C>          <C>    
162,000       $ 2.25-3.75     $ 3.54       2.19 years       162,000       $  3.54
390,000         7.38-9.50       9.13       7.93 years       136,563          8.70
294,000       10.63-11.50      11.08       8.64 years        52,500         11.30
</TABLE>
<PAGE>   17



9.  Stock Option and Purchase Plans (continued)

         Under ILC's Employee Stock Purchase Plan, ILC has 83,033 shares of
common stock available at September 27, 1997 for issuance to participating
employees who have met certain eligibility requirements. The number of shares
available for purchase by each participant is based upon annual base earnings
and at a purchase price equal to 85% of the fair market value at the beginning
or the end of the quarter of purchase, whichever is lower.


10.  Interest Expense, Net

Interest expense, net consists of the following:

<TABLE>
<CAPTION>
                                         1997          1996            1995
                                       --------      --------        --------
<S>                                   <C>            <C>            <C>       
Interest income...................    $(147,210)     $(80,163)      $(265,443)
Interest expense..................      641,127       542,061         589,200
                                       --------      --------        --------

Net interest expense related to
 continuing operations............     $493,917      $461,898        $323,757
                                       ========      ========        ========
</TABLE>



11.  Acquisitions

         In August 1991, ILC acquired all the outstanding stock of Q-Arc Ltd. of
Cambridge, England for $1,400,000 in cash and the assumption of certain
liabilities. Q-Arc is a manufacturer of specialty lamps for laser and non-laser
applications. This transaction was accounted for as a purchase and accordingly,
all assets were revalued to their respective fair values. The acquisition price
was equal to the fair value of net assets acquired. Net assets included a
covenant-not-to-compete of approximately $951,000. The covenant is being
amortized over an eight year period. At September 27, 1997, the unamortized
balance of the Q-Arc covenant-not-to-compete is approximately $238,000.


12.  Discontinued Operations

         In September 1996, ILC's Board of Directors voted to proceed with the
divestiture of PLI which is a subsidiary based in Cotati, California. As a
result of ILC's plan, an estimated loss on disposal of $3,399,000, net of a tax
benefit of $1,133,000, was recorded in the fourth quarter of fiscal 1996. This
loss on disposal included estimated operating losses through the final
disposition of the subsidiary and the write off of the unamortized balance of
the PLI covenant-not-to-compete of approximately $470,000.

         In January 1997, ILC signed an agreement to sell PLI. The original
selling price was approximately $3.3 million but was subject to due diligence
and the ability of PLI Acquisition Corp., the purchaser, to obtain adequate
financing no later than March 31, 1997. The purchaser was not able to obtain
adequate financing, but through further discussions with the purchaser, ILC
agreed to sell the stock of PLI to PLI Acquisition Corp. for a promissory note
with a face value of $4 million bearing 8% interest per year on any unpaid
principal amount. Payments on the promissory note began in May 1997 and will be
completed in April 2000. This transaction was recorded in the third quarter of
fiscal 1997. The purchase price, net of expenses and reserves, approximated the
book value and therefore, no gain or loss was recorded.
<PAGE>   18



12.  Discontinued Operations (continued)

         After conferring with ILC management, PLI Acquisition Corp. did not
make the scheduled October and November 1997 payments on the note payable to
ILC. ILC and PLI Acquisition Corp. are currently evaluating a restructuring of
the payment terms of the note payable to ILC. ILC's management believes that
there has been no impairment of the value of the note as recorded by ILC.

         Continuing operations, as reclassified for fiscal years 1996 and 1995,
consist of the activities of ILC Technology, Inc. based in Sunnyvale,
California, CPI based in Beverly, Massachusetts and Q-Arc based in Cambridge,
England. The Consolidated Statements of Operations have been reclassified to
report separately the activities of PLI as discontinued operations. Revenues
from PLI were $7,772,000 and $8,933,000 for fiscal 1996 and 1995, respectively.
The net loss after tax from the discontinued operations of PLI was $840,000 and
$99,000 for fiscal 1996 and 1995, respectively. A portion of net interest
expense of approximately $66,000 and $58,000 for fiscal 1996 and 1995,
respectively, was allocated to the discontinued operations. Net interest expense
was allocated to discontinued operations based on the ratio of the net assets to
be discontinued to the consolidated net assets plus consolidated debt other than
debt which is directly attributable to continuing operations. For the six months
ended March 29, 1997, revenues from PLI were $1,489,000. Net interest expense
allocated to the discontinued operations of PLI was approximately $18,000. As
discussed above, the resultant loss from discontinued operations was offset
against accruals made in the fourth quarter of fiscal 1996.

         The net assets of PLI of $2,178,383 as of September 28, 1996 are shown
in the accompanying balance sheet as net assets from discontinued operations.
These assets were written down to a value that represented management's best
estimate of the amount that could be realized upon disposition.


13.  Converter Power, Inc.

         In May 1997, ILC completed the sale of CPI to Applied Science and
Technology, Inc. (ASTeX) for $6.35 million in cash and 45,000 shares of ASTeX
common stock. The total sale price was $7.35 million, subject to adjustments
related to warranties. ILC has estimated that $500,000 of potential warranties
could be paid and has reduced the gain on sale accordingly. In August 1997,
ASTeX removed approximately 4,900 shares from escrow based on post-closing audit
adjustments. The remaining shares will be held in escrow subject to any further
post-closing adjustments, with a final settlement in May 1998. The sale, net of
expenses, resulted in a gain of $2,378,683 and was reported in the results of
operations for the third quarter ended June 28, 1997. The net amount due from
ASTeX of $500,000 (to be satisfied by the release to ILC of the ASTeX shares
held in escrow) is reflected in accounts receivable in the accompanying balance
sheet as of September 27, 1997.


14.  Rights Agreement and Other Matters

         On September 19, 1989, ILC's Board of Directors declared a dividend of
one common share purchase right for each outstanding share of common stock, no
par value, of ILC. The dividend was payable on October 2, 1989 to the
shareholders of record on that date. Each right entitles the registered holder
to purchase from ILC one share of common stock of ILC at a price of $15.00 per
common share. The rights will not be exercisable until a party either acquires
beneficial ownership of 20% of ILC's common stock or makes a tender offer for at
least 30% of its common stock. In the event the rights become exercisable and
thereafter a person or group acquires 30% or more of ILC's stock, a 20%
shareholder
<PAGE>   19



14.  Rights Agreement and Other Matters (continued)

("Acquiring Person") engages in any specified self-dealing transaction, or, as a
result of a recapitalization or reorganization, an Acquiring Person's
shareholdings are increased by more than 3%, each right will entitle the holder
to purchase from ILC, for the exercise price, common stock having a market value
of twice the exercise price of the right. In the event the rights become
exercisable and thereafter ILC is acquired in a merger or other business
combination, each right will enable the holder to purchase from the surviving
corporation, for the exercise price, common stock having a market value of twice
the exercise price of the right. At ILC's option, the rights are redeemable in
their entirety, prior to becoming exercisable, at $.01 per right. The rights are
subject to adjustment to prevent dilution and expire September 29, 1999. On
February 25, 1997, the Rights Agreement was amended. The amended terms generally
provide that the exercise of the various rights may occur whenever a party
acquires a beneficial ownership of 15% or more of ILC outstanding common shares
and that registered holders of ILC are entitled to purchase from ILC one share
of common stock at a price of $55.00 per common share. Additionally, the
expiration date of the Rights Agreement was extended to December 31, 2006.

         In November 1996, the Board of Directors authorized eight severance
agreements for six executive officers and two managers, providing for severance
benefits upon termination during the two-year period following a change in
control in ILC, as defined therein.


15.  Repurchase of Common Stock

         In November 1996, the Board of Directors authorized ILC to repurchase
up to 1,000,000 shares of ILC's issued and outstanding common stock. During the
third quarter of fiscal 1997, and since inception of the repurchase program, ILC
repurchased 37,000 shares of common stock for an aggregate amount of $425,458.
Purchases were made on the open market and can be made for up to two years from
the date of authorization.


16.  Subsequent Event

         On October 30, 1997, ILC entered into a definitive Agreement and Plan
of Merger by and among ILC, BEC Group, Inc. ("BEC") and BILC Acquisition Corp.
("Acquisition Corp."), a wholly owned subsidiary of BEC, pursuant to which ILC
will merge (the "Merger") with and into Acquisition Corp. Upon consummation of
the Merger, each outstanding share of ILC will be converted into the right to
receive 2.18 shares (reflecting the completion of BEC's contemplated one-for-two
reverse stock split) of BEC's common stock. The Merger is subject to the
approval of both ILC's shareholders and BEC's stockholders, and to certain
regulatory approvals and other customary closing conditions. The respective
chairmen of ILC and BEC have executed voting agreements in favor of the Merger.
<PAGE>   20



                                                              SCHEDULE VIII

                              ILC TECHNOLOGY, INC.
                 VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
                      FOR FISCAL YEARS 1997, 1996 AND 1995





<TABLE>
<CAPTION>
                            Balance at       Charged to       Deductions      Deductions        Balance at
                            Beginning         Cost and           and             from            end of
                            of Period         Expenses        Write Offs      Dispositions       Period
                            ----------       ----------       ----------      ------------      ----------
<S>                         <C>              <C>              <C>             <C>               <C>       
Allowance for
  Doubtful Accounts:


Year ended
  September 30, 1995        $  332,672       $  102,861       $   26,093         $-------       $  409,440


Year ended
  September 28, 1996        $  409,440       $   38,804       $  135,886               --       $  312,358


Year ended
  September 27, 1997        $  312,358       $   68,694       $   22,062       $   21,032       $  337,958



Reserve for Inventory
  Obsolescence:


Year ended
  September 30, 1995        $2,141,992       $  169,034       $  430,000         $-------       $1,881,026


Year ended
  September 28, 1996        $1,881,026       $  520,006       $  366,774               --       $2,034,258


Year ended
  September 27, 1997        $2,034,258       $  696,089       $  635,927       $   51,000       $2,043,420
</TABLE>
<PAGE>   21





                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS

To ILC Technology, Inc.

         We have audited the accompanying consolidated balance sheets of ILC
Technology, Inc. (a California Corporation) and subsidiaries as of September 27,
1997 and September 28, 1996, and the related consolidated statements of
operations, stockholders' equity and cash flows for each of the three years in
the period ended September 27, 1997. These financial statements and the schedule
referred to below are the responsibility of ILC's management. Our responsibility
is to express an opinion on these financial statements and schedule based on our
audits.

         We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

         In our opinion, the financial statements referred to above present
fairly, in all material respects, the consolidated financial position of ILC
Technology, Inc. and subsidiaries as of September 27, 1997 and September 28,
1996 and the results of their operations and their cash flows for each of the
three years in the period ended September 27, 1997 in conformity with generally
accepted accounting principles.

         Our audit was made for the purpose of forming an opinion on the basic
financial statements taken as a whole. The schedule presented on page 36 is
presented for purposes of complying with the Securities and Exchange
Commission's rules and is not part of the basic financial statements. The
schedule has been subjected to the auditing procedures applied in the audit of
the basic financial statements and, in our opinion, fairly states in all
material respects the financial data required to be set forth therein in
relation to the basic financial statements taken as a whole.





                                              ARTHUR ANDERSEN LLP



San Jose,  California
December 1, 1997







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission